<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65614</article-id><article-id pub-id-type="doi">10.7554/eLife.65614</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to <italic>Toxoplasma gondii</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-221091"><name><surname>Clark</surname><given-names>Joseph T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7764-6000</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221038"><name><surname>Christian</surname><given-names>David A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221039"><name><surname>Gullicksrud</surname><given-names>Jodi A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221040"><name><surname>Perry</surname><given-names>Joseph A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221041"><name><surname>Park</surname><given-names>Jeongho</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221042"><name><surname>Jacquet</surname><given-names>Maxime</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221043"><name><surname>Tarrant</surname><given-names>James C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221044"><name><surname>Radaelli</surname><given-names>Enrico</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221045"><name><surname>Silver</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-221046"><name><surname>Hunter</surname><given-names>Christopher A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3092-1428</contrib-id><email>chunter@upenn.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Kangwon National University College of Veterinary Medicine and Institute of Veterinary Science</institution><addr-line><named-content content-type="city">Chuncheon</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff3"><label>3</label><institution>Liver Immunology, Department of Biomedicine, University Hospital of Basel and University of Basel</institution><addr-line><named-content content-type="city">Basel</named-content></addr-line><country>Switzerland</country></aff><aff id="aff4"><label>4</label><institution>Department of Respiratory Inflammation and Autoimmunity, AstraZeneca</institution><addr-line><named-content content-type="city">Gaithersburg</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Queensland</institution><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Senior Editor</role><aff><institution>Yale School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>30</day><month>04</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65614</elocation-id><history><date date-type="received" iso-8601-date="2020-12-09"><day>09</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-04-29"><day>29</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Clark et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Clark et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65614-v2.pdf"/><abstract><p>IL-33 is an alarmin required for resistance to the parasite <italic>Toxoplasma gondii</italic>, but its role in innate resistance to this organism is unclear. Infection with <italic>T. gondii</italic> promotes increased stromal cell expression of IL-33, and levels of parasite replication correlate with release of IL-33 in affected tissues. In response to infection, a subset of innate lymphoid cells (ILC) emerges composed of IL-33R<sup>+</sup> NK cells and ILC1s. In <italic>Rag1<sup>−/−</sup></italic>mice, where NK cells and ILC1 production of IFN-γ mediate innate resistance to <italic>T. gondii</italic>, the loss of the IL-33R resulted in reduced ILC responses and increased parasite replication. Furthermore, administration of IL-33 to <italic>Rag1<sup>−/−</sup></italic> mice resulted in a marked decrease in parasite burden, increased production of IFN-γ, and the recruitment and expansion of inflammatory monocytes associated with parasite control. These protective effects of exogenous IL-33 were dependent on endogenous IL-12p40 and the ability of IL-33 to enhance ILC production of IFN-γ. These results highlight that IL-33 synergizes with IL-12 to promote ILC-mediated resistance to <italic>T. gondii</italic>.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Toxoplasma gondii</italic></kwd><kwd>IL-33</kwd><kwd>IL-1 family</kwd><kwd>innate lymphoid cells</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>5R01AI125563-05</award-id><principal-award-recipient><name><surname>Hunter</surname><given-names>Christopher A</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>5T32AI00753223</award-id><principal-award-recipient><name><surname>Hunter</surname><given-names>Christopher A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Upon <italic>Toxoplasma gondii</italic> infection, IL-33 plays a critical role in driving early anti-parasite responses by innate lymphoid cells rendered responsive to its effects by infection.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p><italic>Toxoplasma gondii</italic> is an intracellular parasite of public health significance (<xref ref-type="bibr" rid="bib61">Montoya and Liesenfeld, 2004</xref>; <xref ref-type="bibr" rid="bib94">Weiss and Dubey, 2009</xref>; <xref ref-type="bibr" rid="bib31">Israelski and Remington, 1988</xref>). Resistance to this organism is initiated by dendritic cell production of IL-12, which promotes natural killer (NK) and T cell secretion of interferon-γ (IFN-γ) (<xref ref-type="bibr" rid="bib40">Khan et al., 1994</xref>; <xref ref-type="bibr" rid="bib27">Hunter et al., 1994</xref>; <xref ref-type="bibr" rid="bib101">Yap and Sher, 1999a</xref>). IFN-γ in turn induces multiple anti-microbial mechanisms, which include the activation of macrophages to express inducible nitric oxide synthase (iNOS), which are required to limit parasite replication (<xref ref-type="bibr" rid="bib102">Yap and Sher, 1999b</xref>; <xref ref-type="bibr" rid="bib15">Dunay et al., 2010</xref>; <xref ref-type="bibr" rid="bib79">Serbina et al., 2003</xref>; <xref ref-type="bibr" rid="bib76">Scharton-Kersten et al., 1997</xref>; <xref ref-type="bibr" rid="bib93">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Chen et al., 2020</xref>). Previous studies have shown that mice deficient in the adapter molecule MyD88 have increased susceptibility to <italic>T. gondii</italic> associated with reduced production of IL-12 and IFN-γ (<xref ref-type="bibr" rid="bib75">Scanga et al., 2002</xref>; <xref ref-type="bibr" rid="bib11">Del Rio et al., 2004</xref>). Since MyD88 is a major adapter required for Toll-like receptor (TLR) signaling, this increased susceptibility is consistent with a role for TLR-mediated recognition of this pathogen. However, TLR1, TLR2, TLR4, TLR6, TLR9, and TLR11 are individually not required for early resistance to <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib103">Yarovinsky et al., 2005</xref>; <xref ref-type="bibr" rid="bib68">Plattner et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Hitziger et al., 2005</xref>; <xref ref-type="bibr" rid="bib19">Furuta et al., 2006</xref>), and there is a MyD88-independent mechanism of parasite recognition (<xref ref-type="bibr" rid="bib41">Kim et al., 2006</xref>; <xref ref-type="bibr" rid="bib85">Sukhumavasi et al., 2008</xref>; <xref ref-type="bibr" rid="bib56">Mercer et al., 2020</xref>). Moreover, administration of IL-12 to <italic>Myd88<sup>−/−</sup></italic> mice does not restore the ability to produce IFN-γ, and NK and T cell expression of MyD88 is required for optimal production of IFN-γ and resistance to <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib45">LaRosa et al., 2008</xref>; <xref ref-type="bibr" rid="bib21">Ge et al., 2014</xref>). Thus, MyD88 has a critical role in resistance to <italic>T. gondii,</italic> but the events that engage this adapter molecule are unclear.</p><p>Members of the IL-1 family of cytokines, including IL-1α/β, IL-18, and IL-33, utilize distinct receptor sub-units but share downstream signaling machinery that includes MyD88. These cytokines impact a wide range of immune cells and influence many facets of the innate immune system (<xref ref-type="bibr" rid="bib14">Dinarello, 2018</xref>). Mice that lack T and B cells have helped define the impact of cytokines on innate mechanisms of immunity to a wide variety of pathogens (<xref ref-type="bibr" rid="bib69">Powell et al., 2012</xref>; <xref ref-type="bibr" rid="bib59">Monticelli et al., 2011</xref>; <xref ref-type="bibr" rid="bib42">Klose and Artis, 2016</xref>; <xref ref-type="bibr" rid="bib1">Abt et al., 2015</xref>). For example, these models were important to identify the role of IL-12 in promoting NK cell production of IFN-γ required for innate resistance to <italic>Listeria monocytogenes</italic> and <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib2">Bancroft et al., 1991</xref>; <xref ref-type="bibr" rid="bib88">Tripp et al., 1993</xref>; <xref ref-type="bibr" rid="bib26">Hunter et al., 1993</xref>). It is now appreciated that NK cells and ILC1 populations are both relevant sources of IFN-γ that contribute to the control of <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib67">Park et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Weizman et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">López-Yglesias et al., 2020</xref>). Although IL-1 and IL-18 synergize with IL-12 to promote NK cell production of IFN-γ (<xref ref-type="bibr" rid="bib28">Hunter et al., 1995a</xref>; <xref ref-type="bibr" rid="bib6">Cai et al., 2000</xref>; <xref ref-type="bibr" rid="bib39">Kearley et al., 2015</xref>), the role of endogenous IL-1 during toxoplasmosis is secondary to those of IL-12 (<xref ref-type="bibr" rid="bib24">Hitziger et al., 2005</xref>; <xref ref-type="bibr" rid="bib28">Hunter et al., 1995a</xref>; <xref ref-type="bibr" rid="bib55">Melchor et al., 2020</xref>), and endogenous IL-18 is not required for parasite control but rather contributes to the immune pathology that can accompany this infection (<xref ref-type="bibr" rid="bib6">Cai et al., 2000</xref>; <xref ref-type="bibr" rid="bib100">Yap et al., 2001</xref>; <xref ref-type="bibr" rid="bib91">Vossenkämper et al., 2004</xref>; <xref ref-type="bibr" rid="bib16">Ewald et al., 2014</xref>; <xref ref-type="bibr" rid="bib22">Gorfu et al., 2014</xref>). In contrast, endogenous IL-33 has an essential role in resistance to <italic>T. gondii</italic>, but the basis for this protective effect is not well understood (<xref ref-type="bibr" rid="bib36">Jones et al., 2010</xref>).</p><p>IL-33 is a cytokine that is constitutively expressed by endothelial and epithelial cells, and in current models, the death of these cells leads to the release of IL-33 that acts as a damage-associated molecular pattern (DAMP) or alarmin to activate immune cell populations (<xref ref-type="bibr" rid="bib78">Schmitz et al., 2005</xref>; <xref ref-type="bibr" rid="bib63">Moussion et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Liew et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Rostan et al., 2015</xref>). While there are open questions about whether this cytokine can also be secreted (<xref ref-type="bibr" rid="bib44">Kouzaki et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Kakkar et al., 2012</xref>), the rapid oxidation of IL-33 inactivates this cytokine and ensures that its activity is restricted to local sites of tissue damage (<xref ref-type="bibr" rid="bib10">Cohen et al., 2015</xref>). IL-33 and the IL-33R (also termed ST2, encoded by <italic>Il1rl1</italic>) are most prominently associated with amplification of TH2 CD4<sup>+</sup> T cells, activation of ILC2, and resistance to helminths (<xref ref-type="bibr" rid="bib78">Schmitz et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Humphreys et al., 2008</xref>; <xref ref-type="bibr" rid="bib80">Silver et al., 2016</xref>; <xref ref-type="bibr" rid="bib66">Osbourn et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Ricardo-Gonzalez et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Molofsky et al., 2015</xref>), immune regulation by Treg cells (<xref ref-type="bibr" rid="bib54">Matta et al., 2014</xref>; <xref ref-type="bibr" rid="bib77">Schiering et al., 2014</xref>), and a number of metabolic and para-immune functions mediated by ILC2 and regulatory T cells (<xref ref-type="bibr" rid="bib82">Spallanzani et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Ito et al., 2019</xref>). Consistent with its ability to promote TH2-type responses, IL-33 can antagonize inflammation mediated by TH1/TH17 cells during experimental allergic encephalomyelitis (EAE) (<xref ref-type="bibr" rid="bib18">Franca et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Milovanovic et al., 2012</xref>; <xref ref-type="bibr" rid="bib98">Xiao et al., 2018</xref>) and suppresses pathological TH1 responses during visceral leishmaniasis (<xref ref-type="bibr" rid="bib72">Rostan et al., 2013</xref>). However, during infection with LCMV or MCMV, IL-33 promotes the expansion of NK cells and T cells and their production of IFN-γ, and loss of the IL-33R results in a delay in viral clearance (<xref ref-type="bibr" rid="bib65">Nabekura et al., 2015</xref>; <xref ref-type="bibr" rid="bib4">Bonilla et al., 2012</xref>; <xref ref-type="bibr" rid="bib3">Baumann et al., 2015</xref>). In contrast, perhaps one of the most strking phenotypes of mice that lack IL-33R is that they succumb to chronic toxoplasmosis, associated with reduced astrocyte responses required for protective T cell responses (<xref ref-type="bibr" rid="bib36">Jones et al., 2010</xref>; <xref ref-type="bibr" rid="bib83">Still et al., 2020</xref>). Nevertheless, the acute stage of toxoplasmosis is associated with the ability of <italic>T. gondii</italic> to infect and lyse epithelial and endothelial cells (<xref ref-type="bibr" rid="bib43">Konradt et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Van Grol et al., 2013</xref>; <xref ref-type="bibr" rid="bib13">Delgado Betancourt et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Luu et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Ju et al., 2009</xref>), but whether these events lead to the release of IL-33 or if this affects the innate response to Toxoplasma is unknown. The present study reveals that parasite replication during acute toxoplasmosis is associated with the release of IL-33, and <italic>Rag1<sup>−/−</sup></italic> mice that lack the IL-33R have defects in ILC production of IFN-γ and impaired parasite control. Furthermore, administration of IL-33 to <italic>Rag1<sup>−/−</sup></italic> mice enhanced ILC production of IFN-γ associated with the expansion of a population of Ly6c<sup>hi</sup> CCR2<sup>+</sup> inflammatory monocytes and a marked reduction in parasite burden. Together, these results highlight that infection-induced release of IL-33 synergizes with IL-12 to promote ILC production of IFN-γ required for resistance to <italic>T. gondii</italic>.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Toxoplasma gondii</italic> infection induces IL-33 upregulation and release</title><p>To determine the impact of Toxoplasma infection on IL-33 expression and secretion, C57BL/6 WT and <italic>Rag1</italic><sup><italic>−/−</italic></sup> mice were infected intraperitoneally (i.p.) with the Me49 strain or the replication-deficient CPS strain of <italic>T. gondii</italic>, and the levels of IL-33 at local sites of infection and affected tissues assessed by ELISA. In the peritoneum of naïve WT and <italic>Rag1<sup>−/−</sup></italic> mice, the level of IL-33 was below the limit of detection (&lt;10 pg/ml) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Infection i.p. with 2 × 10<sup>5</sup> tachyzoites of the non-replicating CPS strain did not cause parasite-induced host cell lysis and failed to elicit detectable IL-33 at 1 or 5 days post-infection (dpi) (data not shown). Intraperitoneal infection of WT mice with 20 cysts of Me49 resulted in &lt;1% infected cells in the peritoneum at 5 dpi, and IL-33 was not detected by ELISA (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). When <italic>Rag1<sup>−/−</sup></italic> mice received the same challenge, there were 2–5% infected cells at 5 dpi, and elevated levels of IL-33 were present (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). To test whether IL-33 levels were a function of parasite burden, WT and <italic>Rag1<sup>−/</sup><sup><italic>− </italic></sup></italic>mice were treated with anti-IFN-γ, which resulted in a 20-fold increase in parasite load (data not shown) and a threefold to fourfold increase in the levels of IL-33 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). When these data sets were collated and quantity of parasite DNA plotted versus IL-33 concentration, there was a strong correlation between parasite burden and IL-33 levels (R = 0.7902) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). To determine whether IL-33 was released in other tissues affected by <italic>T. gondii</italic>, tissue biopsies from the liver of WT mice at 10 dpi were prepared and placed in culture for 24 hr and IL-33 release measured. While basal levels of IL-33 were detected in tissues from naïve WT mice and mice injected with replication-deficient CPS parasites, the biopsies from infected mice showed significantly elevated levels of IL-33 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). These results suggest that parasite replication and lysis of infected cells lead to IL-33 release, and these levels are comparable to those reported in other inflammatory settings (<xref ref-type="bibr" rid="bib39">Kearley et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Llop-Guevara et al., 2014</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Toxoplasma gondii</italic> infection induces IL-33 expression and release.</title><p>Mice were infected i.p. with <italic>T. gondii.</italic> After 7 days, (<bold>A</bold>) free IL-33 in the peritoneal cavity was measured by ELISA. (<bold>B</bold>) Measurements of IL-33 from (<bold>A</bold>) were plotted against corresponding parasite burden and fit to a linear model. (<bold>C</bold>) Five millimeter punch biopsies of liver was placed in culture for 24 hr and IL-33 measured in supernatants by ELISA. Each point represents the mean of three biopsies from a single mouse. (<bold>D</bold>) Cells from omenta of IL-33 GFP reporter mice were analyzed by flow cytometry at 3 days post-infection. Cells shown are live singlets. Data are representative of three mice per group. (<bold>E</bold>) Whole mount omentum showing IL-33-GFP signal in milky spot. (<bold>F</bold>) 3D projection of milky spot showing stromal marker ERTR7 and IL-33 GFP signal. (<bold>G</bold>) Whole mount immunofluorescence of milky spot. NS, not significant (p&gt;0.05); *p&lt;0.05 and ***p&lt;0.001 (one-way ANOVA with Tukey’s multiple comparisons test). Data are pooled from three (<bold>A and B</bold>) or two (<bold>C, D, E, F, and G</bold>) independent experiments (mean + s.e.m).</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Excel file containing numerical values collected from IL-33 ELISA and parasite DNA qPCR shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65614-fig1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>IL-33 is primarily expressed by non-hematopoietic cells.</title><p>Mice were infected i.p. with <italic>T. gondii.</italic> After 7 days, (<bold>A–C</bold>) Intracellular staining of omenta from infected mice. Data are representative of 3 mice per group, FMO controls are pooled from samples of all genotypes above. (<bold>D</bold>) Immunofluorescence of spleen sections from naïve mouse and intracellular staining flow cytometry from naïve and infected mouse lungs. Data are representative of 3 mice per condition and genotype (<bold>E</bold>) Surface staining of omenta from wild type naïve and infected mice. Data are representative of 3 mice per condition and genotype.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig1-figsupp1-v2.tif"/></fig></fig-group><p>To identify the cellular source of IL-33 during infection, the IL-33-IRES-GFP mouse (<xref ref-type="bibr" rid="bib35">Johnston et al., 2016</xref>), a faithful reporter for IL-33 protein production in comparison to direct staining and <italic>Il33<sup>−</sup></italic><sup>/<italic>−</italic></sup> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), was utilized. The IL-33 reporter mice were infected i.p. with a fluorescent strain of <italic>T. gondii</italic> (Pru-tdTom), and the expression of IL-33-GFP in the omentum was examined by flow cytometry and IHC at 3 dpi. The omentum is an adipose tissue that contains fat-associated lymphoid clusters (FALCs), which are one of the major sites for drainage from the peritoneum (<xref ref-type="bibr" rid="bib9">Christian et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Jackson-Jones et al., 2016</xref>; <xref ref-type="bibr" rid="bib5">Buscher et al., 2016</xref>). In naïve mice, the omentum contained a small population of CD45<sup>+</sup> immune cells, most of which were IL-33-GFP<sup><italic>−</italic></sup>, whereas fibroblastic stromal cells (CD45<sup><italic>−</italic></sup>FSC<sup>hi</sup> SSC<sup>hi</sup> CD31<sup>+/<italic>−</italic></sup> PDPN<sup>+/<italic>−</italic></sup>) were the main source of IL-33-GFP<sup>+</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Upon infection, there was a marked (approximately 7- to 10-fold) expansion of the CD45<sup>+</sup> population and a small population (0.5%) of the CD45<sup>+</sup> F4/80<sup>+</sup> MHCII<sup>+</sup> cells expressed IL-33 (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and data not shown). Nevertheless, although the percentage of stromal cells that expressed IL-33 was decreased (as a consequence of the increased inflammatory populations, compare cell density of plots in <xref ref-type="fig" rid="fig1">Figure 1D</xref>), the major population of IL-33-GFP<sup>+</sup> cells remained fibroblastic stromal cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). The ability to detect infected cells based on parasite expression of tdTomato revealed that infected cells were not associated with IL-33 expression (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), suggesting that infection of individual cells does not directly drive IL-33 expression. Similarly, at 7 dpi, the use of flow cytometry and immunofluorescence revealed that CD45<sup>−</sup> cells were the dominant source of IL-33 in the spleen, lung, and liver (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). By contrast, the majority of IL-33R staining in infected mice was observed on CD45<sup>+</sup> cells, suggesting that hematopoietic cells are the primary responders to IL-33 release (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). To understand the spatial organization of the IL-33-GFP<sup>+</sup> cells, the omentum was used for whole tissue mount immunofluorescence. In uninfected mice, consistent with the analysis above, IL-33 was constitutively expressed by non-hematopoietic CD45<sup>− </sup>cells with fibroblastic morphology distributed throughout the FALCs. At 3 dpi, there was a marked increase in the size of the FALC, and an approximate 3-fold increase in number of IL-33<sup>+</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). These images are max projection views that illustrate the size of FALCs, but quantification of the intensity of fluorescence highlighted the 10-fold increase in the expression of IL-33-GFP (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) associated with ERTR7<sup>+</sup> fibroblastic reticular cells (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Imaging revealed that areas of parasite replication were inversely correlated with the presence of IL-33-GFP expression (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Together, these data establish that in mice acutely infected with <italic>T. gondii</italic> stromal cells are a major source of IL-33, that release of IL-33 correlates with levels of parasite replication, and that a sub-population of innate immune cells express the IL-33R.</p></sec><sec id="s2-2"><title>ILC responses to IL-33</title><p>To identify the cell populations that could respond to the local release of IL-33 during this infection, a UMAP analysis was used to provide an unbiased comparison of the changes in IL-33R expression in the peritoneum of naïve and infected <italic>Rag1</italic><sup>−/−</sup> mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In naïve mice, IL-33R was expressed by peritoneal macrophages (CD64<sup>+</sup>CD11b<sup>+</sup>MHCII<sup>+/−</sup>) and a small population of ILC2 (Lin<sup>−</sup> Nkp46<sup>−</sup>) when compared with <italic>Il1rl1<sup>−/−</sup></italic> controls (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). By 5 dpi, there was a marked change in the cellular composition of the peritoneum with a loss of the MHCII<sup>–</sup> macrophage and ILC2 populations but a prominent monocyte and neutrophil infiltration and the expansion of NKp46<sup>+</sup> NK cells and ILC1s (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, bottom). While there were low levels of IL-33R expressed by MHCII<sup>hi</sup> CD64<sup>+</sup> cells, the highest levels of IL-33R were observed on NKp46<sup>+</sup> cells. Comparison of WT, <italic>Il1rl1<sup>−/−</sup></italic>, and <italic>Il33<sup>−/−</sup></italic> mice revealed that IL-33R expression was not detected on peritoneal or splenic NK cells in naïve mice, but IL-33R was observed on a subset (~20%) of NK cells in the peritoneum by 5 dpi (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Furthermore, NK cells from infected <italic>Il33<sup>−/−</sup></italic> mice still upregulated expression of the IL-33R, indicating that IL-33 signaling is not required for this process. Thus, acute infection of immune competent mice with <italic>T. gondii</italic> is characterized by the emergence of populations of NK cells and ILC1s that express the IL-33R.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Infection sensitizes NK and ILC to IL-33.</title><p>(<bold>A</bold>) UMAP analysis of peritoneal exudate cells from naïve or 7 dpi i.p. mice, with heatmap for IL-33R expression. Data compiled from four mice per group. (<bold>B</bold>) Flow cytometry from peritoneal cells showing IL-33R staining on NKp46+ cells. Data are representative of three to four mice per group. (<bold>C</bold>) Flow cytometry of LAKs showing composition of population based on cytokine stimulation condition. Population shown is pre-gated on live singlets. (<bold>D</bold>) Intracellular cytokine staining of LAKs after 24 hr cytokine stimulation and 4 hr incubation with Brefeldin A. NS, not significant (p&gt;0.05) (Student’s t-test); data are representative of three independent experiments (<bold>A–D</bold>).</p><p> <supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Excel file containing numerical values collected from IL-33R staining and IFN-γ ELISA shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65614-fig2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig2-v2.tif"/></fig><p>To understand the impact of IL-33 on ILC populations, IL-2 induced lymphokine-activated killer cells (LAKs) generated from the bone marrow of <italic>Rag1<sup>−/−</sup></italic> mice (<xref ref-type="bibr" rid="bib30">Hunter et al., 1997</xref>; <xref ref-type="bibr" rid="bib96">Wherry et al., 1991</xref>) were utilized to compare the impact of IL-33 (and its relative IL-18) alone or in combination with IL-12 on ILCs. Phenotyping of these LAK cultures revealed that they contained ILC1s (NKp46<sup>+</sup> CD200R1<sup>+</sup>), ILC2s (NKp46<sup>-</sup> CD200R1<sup>+</sup>) and NK cells (NKp46<sup>+</sup> CD200R1<sup>-</sup>) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Upon withdrawal of IL-2, the addition of IL-33 preferentially stimulated the proliferation of CD200R1<sup>+</sup> ILC2s, while IL-18 stimulated NK cell proliferation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). IL-12 alone did not induce the expansion of a specific cell type, but when combined with IL-33 maintained the heterogeneity of the LAK population, while IL-12 plus IL-18 resulted in a modest increase in the proportion of NK cells compared to IL-18 alone. Moreover, while IL-33 alone did not stimulate LAKs to produce IFN-γ it did synergize with IL-12 to enhance the production of IFN-γ in the NKp46<sup>+</sup> populations (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Similar results were observed when splenocytes from <italic>Rag1<sup>−/−</sup></italic> mice were used (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, bottom right panel) indicating that these effects of IL-33 on NK cells were not dependent on pre-activation with IL-2. These observations are consistent with previous reports on the ability of IL-33 to promote ILC2 activity (<xref ref-type="bibr" rid="bib59">Monticelli et al., 2011</xref>; <xref ref-type="bibr" rid="bib60">Monticelli et al., 2015</xref>), but demonstrate that in the presence of IL-12, IL-33 is a potent inducer of IFN-γ.</p></sec><sec id="s2-3"><title>Endogenous IL-33 is required for innate resistance to <italic>T. gondii</italic></title><p>To directly test the role of endogenous IL-33 in innate resistance to <italic>T. gondii</italic>, <italic>Rag1<sup>−/−</sup></italic> mice that lacked the IL-33R (<italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup></italic> mice) were generated and infected i.p. with <italic>T. gondii</italic>. Compared to <italic>Rag1<sup>−/−</sup></italic> mice, at 7 dpi the <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup></italic> mice showed an increased parasite burden based on the frequency of infected cells in the peritoneum (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and quantitation of parasite DNA in the peritoneum and liver (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Serum analysis of infected mice revealed comparable levels of IL-12p40 in <italic>Rag1<sup>−/−</sup></italic> and <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup></italic> mice, but IFN-γ was severely compromised in the <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup> </italic>mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Similar results were observed in <italic>Rag1</italic>-sufficient WT and <italic>Il1rl1<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B</xref>). At this time point, <italic>Rag1<sup>−/−</sup></italic> mice had a marked expansion in ILC1s and NK cells in the liver that was reduced in the absence of the IL-33R (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Consistent with decreased production of IFN-γ, fewer Ly6c<sup>hi</sup> monocytes were recruited to the liver in the <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup></italic>mice (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Analysis of the Ly6c<sup>hi</sup> population in the liver at 7 dpi after infection with Pru-tdTom showed that a proportion of infected and uninfected cells express iNOS in the <italic>Rag1<sup>−/−</sup></italic>mice, but iNOS levels were markedly reduced in the <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Neutrophil numbers, by contrast, were elevated in <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup></italic> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), although this was not sufficient for parasite control. These data sets establish that endogenous IL-33 is required for optimal production of innate IFN-γ and the recruitment of monocyte populations that express anti-microbial effector mechanisms required for resistance to <italic>T. gondii</italic>.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Endogenous IL-33 promotes the anti-parasitic immune response.</title><p>(<bold>A</bold>) Cytospins of peritoneal exudate cells at 7 dpi i.p. (<bold>B</bold>) qPCR for parasite DNA from indicated tissues. (<bold>C</bold>) Serum cytokines measured by ELISA at 7 dpi. Representative of four to five mice per group. (<bold>D</bold>) Flow cytometric analysis and quantification of liver innate lymphoid cells. Populations shown are pre-gated on live singlets that are MHCII<sup>−</sup>. (<bold>E</bold>) Quantification of inflammatory monocytes (CD11b+CD64+Ly6 g−) in livers of infected mice at 7 dpi. (<bold>F</bold>) Intracellular iNOS staining from monocytes in (<bold>E</bold>), sub-gated on primary iNOS-producing cells (Ly6c<sup>hi</sup> MHCII<sup>lo</sup>). NS, not significant (p&gt;0.05); *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001 (student’s t-test). Data are representative of three independent experiments.</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Excel file containing numerical files collected from cytospin infected cell frequency quantification, parasite DNA qPCR, serum IL-12 and IFN-γ ELISA, and enumeration of cells shown in <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65614-fig3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Endogenous IL-33 promotes anti-parasite responses in WT mice.</title><p>Mice were infected i.p. with <italic>T. gondii.</italic> (<bold>A</bold>) Quantification of serum cytokines from Rag1<sup>+/+</sup> mice at 10 dpi. (<bold>B</bold>) Weight loss curves for mice from (<bold>A</bold>). (<bold>C</bold>) Representative flow cytometric analysis (left) and quantification of numbers (right) of neutrophils in the peritoneum at 7 dpi. Data are representative of three independent experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>IL-33 treatment boosts IL-12- and IFN-γ-dependent immunity</title><p>Based on the ability of IL-33 to stimulate IL-12-dependent IFN-γ production in ILC1s and NK cells, a recombinant version of IL-33, resistant to oxidation which has a 30-fold increase in efficacy (<xref ref-type="bibr" rid="bib39">Kearley et al., 2015</xref>; <xref ref-type="bibr" rid="bib10">Cohen et al., 2015</xref>), was utilized to determine if exogenous IL-33 could be used to enhance innate resistance to <italic>T. gondii</italic>. Beginning at 1 dpi, IL-33 was administered i.p. every 2 days until 7 dpi, which resulted in a dose-dependent reduction in the frequency of infected cells at the site of infection and a decrease in parasite DNA in multiple tissues (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Analysis of cytospins of PECs revealed that treatment of infected <italic>Rag1<sup>−/−</sup></italic> mice with IL-33 resulted in the emergence of a highly activated monocyte population (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). By contrast, neutrophil numbers were not affected by IL-33 treatment (data not shown). These inflammatory monocytes were larger (higher FSC) and more granular (higher SSC) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Furthermore, these cells were characterized by their expression of CD11b, CD11c, Ly6c, CCR2, and MHCII (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). IL-33 treatment also resulted in increased recruitment of Ly6c<sup>hi</sup> CCR2<sup>+</sup> inflammatory monocytes to the liver and lungs by 7 dpi, and these monocytes had enhanced iNOS and IL-33R expression (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Histological analysis of the liver confirmed that IL-33 treatment resulted in increased cellular infiltration and expression of iNOS (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, black arrows). Importantly, these changes induced by IL-33 treatment were associated with decreased necrotic foci that were frequent in infected <italic>Rag1<sup>−/−</sup> </italic>mice (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, blue arrow). These results correlate the protective effects of IL-33 treatment with an increase in macrophage and monocyte responses required for the control of <italic>T. gondii</italic>.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>IL-33 treatment boosts IL-12- and IFN-γ-dependent immunity.</title><p>(<bold>A</bold>) Quantification of infected cell frequencies in cytospins at 7 dpi i.p. and qPCR for parasite DNA in indicated tissues. (<bold>B</bold>) Representative cytospins from peritoneal lavage at 7 dpi. Data are representative of four to six mice per group. (<bold>C</bold>) Flow cytometric analysis of inflammatory monocytes in the peritoneal exudate at 7 dpi. Populations shown are pre-gated on live Ly6g<sup>−</sup> singlets. Ly6c<sup>hi</sup> CCR2<sup>+</sup> cells are highlighted in black. (<bold>D</bold>) Representative analysis of Ly6c<sup>+</sup> CCR2<sup>+</sup> cells at 7 dpi in the liver and quantification of monocyte numbers and iNOS staining. (<bold>E</bold>) Histology of liver at 7 dpi, H and E showing infiltration of immune cells (left) and DAB iNOS staining (right). Black arrows indicate inflammatory infiltration; blue arrow indicates necrotic lesion. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001 (Student’s t-test). Data are representative of five (<bold>A–C</bold>) or three (<bold>D–E</bold>) independent experiments.</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Excel file containing numerical values collected from cytospin infected cell frequency quantification, cell counts, and iNOS staining shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65614-fig4-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig4-v2.tif"/></fig><p>To determine whether the protective effects of exogenous IL-33 depended on the ability of IL-12 to promote ILC production of IFN-γ, infected <italic>Rag1<sup>−/−</sup></italic> mice were treated with IL-33 in combination with either anti-IL-12p40 or anti-IFN-γ neutralizing antibodies. Additionally, <italic>Rag2<sup>−/−</sup></italic>; <italic>Il2rg<sup>−/−</sup></italic> mice, which lack ILCs, were treated with PBS or IL-33. Blockade of either IL-12 or IFN-γ entirely abrogated the protective effects of IL-33 treatment as measured by the frequency of infected cells in the peritoneum at 7 dpi (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). As expected, <italic>Rag2<sup>−/−</sup></italic>; <italic>Il2rg<sup>−/−</sup></italic> mice were more susceptible than <italic>Rag1<sup>−/−</sup></italic> mice, and IL-33 treatment did not affect parasite burden in the peritoneum. IFN-γ levels at the site of infection were increased by IL-33 treatment in ILC-sufficient <italic>Rag1<sup>−/−</sup></italic> animals, but were unaffected in <italic>Rag2<sup>−/−</sup></italic>; <italic>Il2rg<sup>−/−</sup></italic> animals (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In <italic>Rag1<sup>−/−</sup></italic> mice, treatment with IL-33 resulted in an expansion of the NK and ILC1 compartments and their production of IFN-γ (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The expansion of Ly6c<sup>hi</sup> CCR2<sup>+</sup> monocytes associated with protection was also dependent on these factors, as cytokine blockade or absence of innate lymphoid cells resulted in the loss of these cells (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5">Figure 5E</xref>). These results suggest that the protective effects of IL-33 are not working through effects on the monocytes but rather that the ability of exogenous IL-33 to promote parasite control are dependent on IL-12 and ILC production of IFN-γ and subsequent activation of inflammatory monocytes.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Protective effect of IL-33 is dependent on IL-12, IFN-γ, and ILC.</title><p>(<bold>A</bold>) Quantification of cytospins from peritoneal exudate cells at 7 dpi i.p. (<bold>B</bold>) Quantification of IFN-γ in peritoneal lavage at 7 dpi. (<bold>C</bold>) Representative flow cytometric analysis of NK cells and ILC1s (left) and quantification of cell numbers and cytokine production (right) in the peritoneal exudate at 7 dpi. Population shown is pre-gated on live Ly6g<sup>-</sup> NKp46<sup>+</sup> singlets. (<bold>D and E</bold>) Flow cytometric analysis of inflammatory monocytes in peritoneum at 7 dpi. Data are representative of two independent experiments.</p><p> <supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Excel file containing numerical values collected from cytospin infected cell frequency quantification, IFN-γ ELISA, and enumeration of cells shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65614-fig5-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig5-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Previous studies have identified a central role for IL-12 in innate and adaptive production of IFN-γ required for control of <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib40">Khan et al., 1994</xref>; <xref ref-type="bibr" rid="bib27">Hunter et al., 1994</xref>; <xref ref-type="bibr" rid="bib20">Gazzinelli et al., 1993</xref>; <xref ref-type="bibr" rid="bib29">Hunter et al., 1995b</xref>; <xref ref-type="bibr" rid="bib99">Yap et al., 2000</xref>; <xref ref-type="bibr" rid="bib97">Wilson et al., 2008</xref>), but other cytokines and costimulatory pathways potentiate the effects of IL-12 on NK cells. In particular, IL-1 and IL-18 can amplify NK cell production of IFN-γ, but evidence that endogenous IL-1 and IL-18 are critical for control of <italic>T. gondii</italic> in this model is limited. Thus, while IL-1 or IL-18 contribute to the development of infection-induced, microbiome-dependent immune mediated pathology in the gut, there is limited evidence that loss of IL-1 or IL-18 leads to increased parasite replication (<xref ref-type="bibr" rid="bib24">Hitziger et al., 2005</xref>; <xref ref-type="bibr" rid="bib45">LaRosa et al., 2008</xref>; <xref ref-type="bibr" rid="bib55">Melchor et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Vossenkämper et al., 2004</xref>; <xref ref-type="bibr" rid="bib62">Mordue et al., 2001</xref>; <xref ref-type="bibr" rid="bib84">Struck et al., 2012</xref>; <xref ref-type="bibr" rid="bib64">Muñoz et al., 2015</xref>; <xref ref-type="bibr" rid="bib90">Villeret et al., 2013</xref>). Indeed, early studies showed that neutralization of endogenous IL-18 did not affect levels of parasite replication and that in SCID mice treated with IL-12 the effects of IL-1R blockade were modest and these treated mice were still more resistant than untreated SCID mice (<xref ref-type="bibr" rid="bib28">Hunter et al., 1995a</xref>). It is relevant to note that recent work has highlighted a cell intrinsic role for MyD88 in NK cells to help control <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib21">Ge et al., 2014</xref>), but neither IL-1 blockade or the use of IL-1R<italic><sup>−/−</sup></italic> and IL-18<italic><sup>−/−</sup></italic> mice replicates the susceptibility of <italic>Myd88<sup>−/−</sup></italic>mice (<xref ref-type="bibr" rid="bib45">LaRosa et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Hitziger et al., 2005</xref>). In the studies presented here, the reduced NK and ILC responses observed in <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>-/-</sup></italic> mice suggest that the ability of IL-33 (rather than IL-1 or IL-18) to amplify the IL-12-mediated innate response to acute toxoplasmosis helps explain the role for MyD88 in innate resistance to <italic>T. gondii</italic>. It is increasingly appreciated that in addition to NK cells, tissue resident ILC1s are an early source of IFN-γ in the innate response to <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib67">Park et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Weizman et al., 2017</xref>), but the differential programming of these cells, including their responsiveness to the IL-1 family member cytokines, is still being described. While IL-12 is central to NK and ILC1 production of IFN-γ, there are other stimuli that can potentiate this pathway (<xref ref-type="bibr" rid="bib92">Walker et al., 1999</xref>). Certainly in vitro, in the presence of IL-12, IL-33 can promote NK cells and ILC1 IFN-γ production. While IL-18 is a more potent stimulator of IFN-γ in LAK cultures, the ability of IL-33 to promote NK and ILC1 responses, combined with the defects seen in these populations in <italic>Il1rl1</italic><sup>-/-</sup> mice, suggests that of all the IL-1 family members, IL-33 is uniquely important for innate lymphoid cell responses to Toxoplasma.</p><p>Because the signaling pathways for the IL-1 family members converge on MyD88-dependent activation of NF-κB, differences in expression patterns and tissue localization are likely to dictate the relative importance of each cytokine. The release of IL-1 and IL-18 is typically considered to be downstream of inflammasome-mediated caspase activation and processing of pro-forms of these cytokines (<xref ref-type="bibr" rid="bib53">Man and Kanneganti, 2015</xref>). While there is evidence that pro-IL-1 and pro-IL-18 are produced during toxoplasmosis (<xref ref-type="bibr" rid="bib26">Hunter et al., 1993</xref>; <xref ref-type="bibr" rid="bib104">Zediak and Hunter, 2003</xref>), several studies have concluded that <italic>T. gondii</italic> does not readily activate inflammasomes and there is evidence that Toxoplasma suppresses inflammasome activity (<xref ref-type="bibr" rid="bib16">Ewald et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Lima et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Liu et al., 2019</xref>). However, there is a report that the inflammasome sensors NLRP1 and NLRP3 are required for protective immunity to <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib22">Gorfu et al., 2014</xref>). A possible explanation for this discrepancy is that some inflammasome components are not just microbial sensors but have additional functions that include a role for Caspase eight in the activation of the c-Rel transcription factor required for expression of IL-12 and resistance to <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib12">DeLaney et al., 2019</xref>). To date, no murine sensor of Toxoplasma or parasite ligand has been identified that directly activates inflammasomes, although there is evidence for sensor-independent routes for inflammasome activation (<xref ref-type="bibr" rid="bib74">Sandstrom et al., 2019</xref>). In contrast to the complex events that lead to the production and processing of IL-1 and IL-18, IL-33 is expressed constitutively by epithelial and endothelial cells at barrier sites and stored in the nucleus, and may therefore be resistant to parasite mechanisms of immune evasion and suppression that target host cell transcription. The release of IL-33 can occur as a consequence of tissue damage associated with allergic inflammation or viral infection (<xref ref-type="bibr" rid="bib4">Bonilla et al., 2012</xref>; <xref ref-type="bibr" rid="bib80">Silver et al., 2016</xref>), and during toxoplasmosis, IL-33 levels correlated closely with levels of parasite replication and host cell lysis. Thus, even though there may be non-canonical pathways for IL-33 release (<xref ref-type="bibr" rid="bib44">Kouzaki et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Kakkar et al., 2012</xref>; <xref ref-type="bibr" rid="bib82">Spallanzani et al., 2019</xref>; <xref ref-type="bibr" rid="bib81">Snelgrove et al., 2014</xref>; <xref ref-type="bibr" rid="bib7">Chen et al., 2015</xref>), it seems likely that these physiological levels of IL-33 are a consequence of parasite-mediated lysis of infected cells.</p><p>Treatment of infected mice with exogenous IL-33 confirmed the protective effects of IL-33 and highlighted the impact on the recruitment of inflammatory monocytes to sites of infection and the subsequent upregulation of iNOS, a process required for the control of <italic>T. gondii</italic> (<xref ref-type="bibr" rid="bib102">Yap and Sher, 1999b</xref>; <xref ref-type="bibr" rid="bib15">Dunay et al., 2010</xref>; <xref ref-type="bibr" rid="bib79">Serbina et al., 2003</xref>; <xref ref-type="bibr" rid="bib76">Scharton-Kersten et al., 1997</xref>). IL-33 drives ILC-cell-dependent recruitment of CCR2<sup>+</sup> inflammatory monocytes, which resemble the TipDCs (TNF and iNOS-producing dendritic cells) previously shown to be important for control of infection (<xref ref-type="bibr" rid="bib77">Schiering et al., 2014</xref>; <xref ref-type="bibr" rid="bib82">Spallanzani et al., 2019</xref>). This finding is similar to an allergy model in which IL-33 contributes to the CCR2-dependent recruitment of inflammatory monocytes (<xref ref-type="bibr" rid="bib86">Tashiro et al., 2016</xref>). It has been reported that IL-33 can directly enhance monocyte production of iNOS (<xref ref-type="bibr" rid="bib46">Li et al., 2014</xref>), but in the studies reported here, the ability of exogenous IL-33 to promote this population of IL-33R<sup>+</sup> monocytes was dependent on ILC and the production of IFN-γ suggests that IL-33 is not sufficient to expand these monocytes. Additional experiments will be required to directly assess the contribution of the IL-33R to the regulation of monocyte function. It is also important to note that endogenous IL-33 is susceptible to rapid inactivation via oxidation in the extracellular space, which restricts its effects spatially and temporally. However, the recombinant IL-33 used in these studies was engineered to resist oxidation and it is possible that this treatment approach may have wider activities on hematopoiesis than IL-33 produced at sites of inflammation.</p><p>While IL-33 is most prominently linked to the regulation of Th2 type responses, there are reports that highlight the context dependent role that IL-33 plays in TH1 responses. In models of Leishmaniasis and cerebral malaria, IL-33 contributes to T-cell-dependent immune pathology in the skin and brain, respectively (<xref ref-type="bibr" rid="bib72">Rostan et al., 2013</xref>; <xref ref-type="bibr" rid="bib70">Reverchon et al., 2017</xref>). However, with the viral pathogens MCMV and LCMV, IL-33 contributes to NK and T cell expansion, and in its absence, there is a delay in viral clearance, but in neither case, is IL-33 essential for protective immunity (<xref ref-type="bibr" rid="bib39">Kearley et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Nabekura et al., 2015</xref>). Indeed, during intracerebral LCMV infection IL-33 contributes to the development of lethal immune pathology (<xref ref-type="bibr" rid="bib4">Bonilla et al., 2012</xref>), whereas for mice chronically infected with <italic>T. gondii</italic>, the loss of IL-33 results in increased parasite burden (<xref ref-type="bibr" rid="bib36">Jones et al., 2010</xref>). More recent studies have highlighted that IL-33 promotes astrocyte responses required for control of <italic>T. gondii</italic> in the CNS (<xref ref-type="bibr" rid="bib83">Still et al., 2020</xref>). Nevertheless, the data presented here establish that the ability of IL-33 to amplify ILC responses and their production of IFN-γ plays a protective role in the acute innate response to Toxoplasma (see <xref ref-type="fig" rid="fig6">Figure 6</xref>). These results are consistent with a model in which IL-33 has a protective rather than pathological role in the immune response to <italic>T. gondii</italic>.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Model for the role of IL-33 in innate immunity to <italic>Toxoplasma gondii</italic>.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65614-fig6-v2.tif"/></fig></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/><break/>information</th></tr></thead><tbody><tr><td>Gene (<italic>Mus musculus)</italic></td><td><italic>Il33</italic></td><td>GenBank</td><td><ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/marker/MGI:1924375">MGI:1924375</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gene/77215">https://www.ncbi.nlm.nih.gov/gene/77215</ext-link></td></tr><tr><td>Gene (<italic>Mus musculus</italic>)</td><td><italic>Il1rl1</italic></td><td>GenBank</td><td><ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/marker/MGI:98427">MGI:98427</ext-link></td><td><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gene/17082">https://www.ncbi.nlm.nih.gov/gene/17082</ext-link></td></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>C57BL/6NTac</td><td>Taconic</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:5658006">MGI:5658006</ext-link></td><td/></tr><tr><td>Genetic reagent <break/>(<italic>Mus musculus</italic>)</td><td>B6.129S7-<italic>Rag1</italic><sup>tm1Mom</sup>/J</td><td>Jackson</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:002216">IMSR_JAX:002216</ext-link></td><td/></tr><tr><td>Genetic reagent <break/>(<italic>Mus musculus</italic>)</td><td>C57BL/6NTac.<italic>Rag2</italic><sup>tm1Fwa</sup>;<italic>II2rg</italic><sup>tm1Wjl</sup></td><td>Taconic</td><td>Cat # 4111</td><td/></tr><tr><td>Genetic reagent <break/>(<italic>Mus musculus</italic>)</td><td>B6(129S4)-Il33<sup>tm1.1Bryc</sup>/J</td><td>Jackson</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:030619">IMSR_JAX:030619</ext-link></td><td/></tr><tr><td>Genetic reagent <break/>(<italic>Mus musculus</italic>)</td><td><italic>Il1rl1<sup>tm1Anjm</sup></italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10727469/">10727469</ext-link> <xref ref-type="bibr" rid="bib87">Townsend et al., 2000</xref></td><td>MGI:2386675</td><td><ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/allele/MGI">http://www.informatics.jax.org/allele/MGI</ext-link>:2386675</td></tr><tr><td>Strain, strain background (<italic>Toxoplasma gondii</italic>)</td><td>ME49</td><td>NCBI:txid508771</td><td/><td/></tr><tr><td>Strain, strain background (<italic>Toxoplasma gondii</italic>)</td><td>Pru-tdTomato</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19578440/">19578440</ext-link> <xref ref-type="bibr" rid="bib34">John et al., 2009</xref></td><td/><td/></tr><tr><td>Strain, strain background (<italic>Toxoplasma gondii</italic>)</td><td>CPS</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11859373/">11859373</ext-link> <xref ref-type="bibr" rid="bib17">Fox and Bzik, 2002</xref></td><td/><td/></tr><tr><td>Antibody</td><td><italic>Toxoplasma gondii</italic> <break/>Rabbit polyclonal</td><td>Collaborator</td><td/><td>IHC: 1:100</td></tr><tr><td>Antibody</td><td>iNOS <break/>Rabbit polyclonal</td><td>Abcam</td><td>Cat # ab15323, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_301857">AB_301857</ext-link></td><td>IHC 1:50</td></tr><tr><td>Antibody</td><td>ERTR7 Af647 <break/>Rat monoclonal (sc-73355)</td><td>Santa Cruz Biotechnology</td><td>Cat # sc-73355 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1122890">AB_1122890</ext-link></td><td>IF (1:50)</td></tr><tr><td>Antibody</td><td>F4/80 BV480 <break/>Rat monoclonal (T45-2342)</td><td>BD</td><td>Cat # 565635 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2739313">AB_2739313</ext-link></td><td>IF (1:25)</td></tr><tr><td>Antibody</td><td>CD45 Af700 <break/>Rat monoclonal (30-F11)</td><td>BioLegend</td><td>Cat # 103127, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493714">AB_493714</ext-link></td><td>IF (1:20)</td></tr><tr><td>Antibody</td><td>CD335 NKp46 <break/>PE/Dazzle 594 <break/>Rat monoclonal (29A1.4)</td><td>BioLegend</td><td>Cat # 137629, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2616665">AB_2616665</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>NK-1.1 BV711 <break/>Mouse monoclonal (PK136)</td><td>BioLegend</td><td>Cat # 108745, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2563286">AB_2563286</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>IFN gamma Af700 <break/>Rat monoclonal (XMG1.2)</td><td>Thermo Fisher</td><td>Cat # 56-7311-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2688063">AB_2688063</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>CD200 Receptor APC <break/>Rat monoclonal (OX110)</td><td>Thermo Fisher</td><td>Cat # 17-5201-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10717289">AB_10717289</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>T1/ST2 Biotin <break/>Rat monoclonal (DJ8)</td><td>MD Biosciences</td><td>Cat # 101001B, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_947551">AB_947551</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>T-bet PE-Cy7 <break/>Mouse monoclonal (4B10)</td><td>BioLegend</td><td>Cat # 644823</td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>EOMES PE <break/>Rat monoclonal (Dan11mag)</td><td>Thermo Fisher</td><td>Cat # 12-4875-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1603275">AB_1603275</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>CD11b ef450 <break/>Rat monoclonal (M1/70)</td><td>Thermo Fisher</td><td>Cat # 48-0112-80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1582237">AB_1582237</ext-link></td><td>FC (1:1000)</td></tr><tr><td>Antibody</td><td>CD11c APC-ef780 <break/>Armenian hamster monoclonal (N418)</td><td>Thermo Fisher</td><td>Cat# 47-0114-80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1548663">AB_1548663</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>Ly-6C BV785 <break/>Rat monoclonal (HK1.4)</td><td>BioLegend</td><td>Cat # 128041, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2565852">AB_2565852</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>Ly-6G BV711 <break/>Rat monoclonal (1A8)</td><td>BioLegend</td><td>Cat # 127643, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2565971">AB_2565971</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>CCR2 CD192 APC <break/>Rat monoclonal (SA203G11)</td><td>BioLegend</td><td>Cat # 150628, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2810415">AB_2810415</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>CD64 FcgammaRI PE-Cy7 <break/>Mouse monoclonal (X54-5/7.1)</td><td>BioLegend</td><td>Cat # 139306, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11219391">AB_11219391</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>MHC Class II (I-A/I-E) Af700 <break/>Rat monoclonal (M5/114.15.2)</td><td>Thermo Fisher</td><td>Cat # 56-5321-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_494009">AB_494009</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>iNOS APC <break/>Rat monoclonal (CXNFT)</td><td>Thermo Fisher</td><td>Cat # 17-5920-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2573244">AB_2573244</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>Podoplanin gp38 PerCP-ef710 <break/>Syrian hamster monoclonal (eBio8.1.1)</td><td>Thermo Fisher</td><td>Cat # 46-5381-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2848339">AB_2848339</ext-link></td><td>FC (1:200)</td></tr><tr><td>Antibody</td><td>CD31 BV605 <break/>Rat monoclonal (390)</td><td>BioLegend</td><td>Cat # 102427, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2563982">AB_2563982</ext-link></td><td>FC (1:200)</td></tr><tr><td>Peptide, recombinant protein</td><td>Recombinant murine IL-33</td><td>Peprotech</td><td>Cat # 210–33</td><td/></tr><tr><td>Commercial assay or kit</td><td>IL-33 ELISA</td><td>R and D Biosystems</td><td>Cat # DY3626</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>B6 (C57BL/6NTac) (Taconic #B6-F), <italic>Rag1<sup>−/−</sup></italic> (B6.129S7-<italic>Rag1</italic><sup>tm1Mom</sup>/J) (Jackson #002216), and <italic>Rag2<sup>−/−</sup></italic>; <italic>Il2rg<sup>−/−</sup></italic>(C57BL/6NTac.<italic>Rag2</italic><sup>tm1Fwa</sup>;<italic>II2rg</italic><sup>tm1Wjl</sup>) (Taconic #4111) mice were purchased from their respective vendors. <italic>Il33<sup>−/−</sup></italic> (<italic>Il33</italic><sup>tm1.1Arte</sup>) (Jackson #350163) mice were provided by MedImmune (now AstraZeneca). <italic>Il33</italic><sup>fl/fl</sup>-eGFP (B6(129S4)-Il33<sup>tm1.1Bryc</sup>/J), originally generated by Paul Bryce, were obtained locally from Dr. De’Broski Herbert. IL-33R KO (<italic>Il1rl1<sup>−/−</sup></italic>) mice, originally derived by Andrew McKenzie (<xref ref-type="bibr" rid="bib87">Townsend et al., 2000</xref>) (University of Cambridge) and back-crossed to C57BL/6 by Peter Nigrovic (Harvard University), were provided by Edward Behrens at Children’s Hospital of Philadelphia. <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1<sup>−/−</sup></italic> mice were generated by crossing the knockouts described above. Analysis of these uninfected KO mice revealed no obvious developmental defects, while their immune compartments appeared comparable to <italic>Rag1<sup>−/−</sup></italic>; <italic>Il1rl1</italic><sup>+/+</sup> mice in cell numbers and phenotype at homeostasis. Mice were housed in a specific pathogen-free environment at the University of Pennsylvania School of Veterinary Medicine and treated according to protocols approved by the Institutional Animal Care and Use Committee at the University. Male and female (age 8–12 weeks at start of experiment) mice were used for all experiments.</p></sec><sec id="s4-2"><title>Parasites and infection</title><p>The ME49 strain of <italic>T. gondii</italic> was maintained by serial passage in Swiss Webster mice and used to generate banks of chronically infected CBA/ca mice, which were a source of tissue cysts for these experiments. Pru-derived transgenic parasites and CPS parasites were maintained in cultured human fibroblasts in DMEM supplemented with 10% FBS. For CPS parasites, supplemental uracil was also added to media. For all experiments presented here, mice were infected intraperitoneally (i.p.) with 20 cysts (ME49), or 1 × 10<sup>4</sup> tachyzoites (Pru), or 2 × 10<sup>5</sup> tachyzoites (CPS). Soluble toxoplasma antigen was prepared from tachyzoites of the RH strain as described previously (<xref ref-type="bibr" rid="bib23">Hauser et al., 1983</xref>). For quantitative PCR (qPCR), DNA was isolated from tissues using the DNEasy DNA isolation kit (Qiagen) followed by qPCR measuring the abundance of the <italic>T. gondii</italic> gene B1 using the primers 5′-<named-content content-type="sequence">TCTTTAAAGCGTTCGTGGTC</named-content>-3′ (forward) and 5′-<named-content content-type="sequence">GGAACTGCATCCGTTCATGAG</named-content>-3′ (reverse).</p></sec><sec id="s4-3"><title>Histology</title><p>For IHC detection of <italic>T. gondii</italic> and iNOS, tissues were fixed in 10% formalin solution and then paraffin embedded and sectioned. Sections were deparaffinized, rehydrated, Ag retrieved in 0.01 M sodium citrate buffer (pH 6.0), and endogenous peroxidase blocked by 0.3% H<sub>2</sub>O<sub>2</sub> in PBS. After blocking with 2% normal goat serum, the sections were incubated either with rabbit anti-Toxoplasma Ab, anti-INOS Ab, or isotype control. The sections were then incubated with biotinylated goat anti-rabbit IgG (Vector, Burlingame, CA), and ABC reagent was applied (Vectastain ABC Kit; Vector Labs). Then DAB substrate (Vector Labs) was used to visualize specific staining according to manufacturer’s instructions, and slides were counterstained with hematoxylin. To quantify parasite burden in the peritoneal exudate, 100,000 cells were used to prepare cytospins. Cells were methanol fixed and then stained with the Protocol Hema-3 Stain Set, and the ratio of infected cells to total cells in a field of view was calculated, with a minimum of 200 cells counted per sample. For whole tissue mount immunofluorescence staining, omenta were harvested from mice and fixed in 1% PFA overnight at 4°C. After rinsing, tissue was blocked using 10% bovine serum albumin (BSA), 0.5% normal rat serum (Invitrogen), and 1 µg/ml 2.4G2 (BD) in PBS for 1 hr at room temperature. Omenta were next incubated in PBS containing primary antibodies at 4°C for 3 days and subsequently rinsed with PBS overnight. Antibodies used for this analysis: ERTR7 (sc-73355, Santa Cruz Biotechnology), F4/80 (T45-2342, BD), and CD45 (30-F11, Biolegend).</p><p>Immunofluorescence combining IL-33 (R and D AF3626) and CD45 (Biolegend 30-F11) antibodies was performed using the OPAL Automation Multiplex IHC Detection Kit (Akoya Biosciences, Cat # 160 #NEL830001KT) implemented onto a BOND Research Detection System (DS9455). All widefield images were obtained on a Leica DM6000 microscope using the Leica Imaging Suite software. Confocal images were acquired on a Leica STED 3× Super-resolution microscope. Image analysis was performed using FIJI and Imaris software packages.</p></sec><sec id="s4-4"><title>Generation of lymphokine-activated killer cells</title><p>Lymphokine-activated killer cells (LAKs) were generated from <italic>Rag1<sup>−/−</sup></italic>bone marrow as described previously (<xref ref-type="bibr" rid="bib30">Hunter et al., 1997</xref>; <xref ref-type="bibr" rid="bib96">Wherry et al., 1991</xref>). Briefly, whole bone marrow was plated at 1 M cells/ml in cRPMI +400 U/ml Proleukin human IL-2 (Peprotech). Fresh IL-2 was added every third day, and cells were used for experiments between days 7 and 10.</p></sec><sec id="s4-5"><title>Antibody and cytokine reagents</title><p>For in vitro assays, recombinant IL-33 was purchased from Peprotech (Cat # 210–33 Rocky Hill, NJ). For in vivo treatment experiments, recombinant IL-33 (MedImmune), which was modified to be resistant to oxidation, was used, as described previously (<xref ref-type="bibr" rid="bib10">Cohen et al., 2015</xref>). IL-33 DuoSet ELISA was purchased from R and D Biosystems (Cat # DY3626, Minneapolis, MN). For flow cytometry, the following combinations of antibodies were used: for analysis of NK cells: CD335 NKp46 (29A1.4, eBioscience), NK-1.1 (PK136, Biolegend), IFN-γ (XMG1.2, eBioscience), CD200R1 (OX110, eBioscience), IL-33R (DJ8, MD Biosciences), T-bet (4B10, Biolegend), and EOMES (Dan11mag, eBioscience). For analysis of myeloid cells: CD11b (M1/70, eBioscience), CD11c (N418, Biolegend), Ly6c (HK1.4, Biolegend), Ly6g (1A8, Biolegend), CCR2 CD192 (SA203G11, Biolegend), CD64 FcgRI (X54-5/7.1, Biolegend), MHC II I-A/I-E (m5/114.15.2, eBioscience), iNOS (CXNFT, eBioscience), IL-33R (DJ8, MD Biosciences). For analysis of stromal cells: gp38/PDPN (8.1.1, Biolegend), CD31 (390, Biolegend). Flow cytometry was performed on BD Fortessa and X-50 cytometers, and data analysis was performed using Flowjo nine and Flowjo 10 (Treestar), and Prism 7 and 8 (Graphpad). Uniform Manifold Approximation and Projection for Dimension Reduction (uMAP) analysis was performed using the uMAP plug-in (version: 1802.03426, 2018, 2017, Leland McInness) for Flowjo (Version 10.53). The Euclidean distance function was utilized with a nearest neighbor score of 15 and a minimum distance rating of 0.5.</p></sec><sec id="s4-6"><title>Quantification and statistical analysis</title><p>All data are expressed as means ± standard error of the mean (SEM). For comparisons between two groups, the Student’s t-test was applied. For data with more than two data sets, one-way ANOVA coupled with Tukey’s multiple comparisons test was applied. Statistical details are indicated in figure legends.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors would like to acknowledge the contributions of the Penn Vet Imaging Core and the Comparative Pathology Core at the University of Pennsylvania School of Veterinary Medicine, and the members of the Hunter laboratory for scientific and moral support. The model in <xref ref-type="fig" rid="fig6">Figure 6</xref> was generated using assets from <ext-link ext-link-type="uri" xlink:href="https://biorender.com/">BioRender.com</ext-link>. This work was supported by grants from the National Institutes of Health: NIAID 5R01AI125563 and 5T32-AI007532-21</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>is a full-time employee and shareholder of AstraZeneca.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Software, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#805045) of the University of Pennsylvania.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-65614-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abt</surname> <given-names>MC</given-names></name><name><surname>Lewis</surname> <given-names>BB</given-names></name><name><surname>Caballero</surname> <given-names>S</given-names></name><name><surname>Xiong</surname> <given-names>H</given-names></name><name><surname>Carter</surname> <given-names>RA</given-names></name><name><surname>Sušac</surname> <given-names>B</given-names></name><name><surname>Ling</surname> <given-names>L</given-names></name><name><surname>Leiner</surname> <given-names>I</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection</article-title><source>Cell Host &amp; Microbe</source><volume>18</volume><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.06.011</pub-id><pub-id pub-id-type="pmid">26159718</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bancroft</surname> <given-names>GJ</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name><name><surname>Unanue</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse</article-title><source>Immunological Reviews</source><volume>124</volume><fpage>5</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.1991.tb00613.x</pub-id><pub-id pub-id-type="pmid">1804781</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname> <given-names>C</given-names></name><name><surname>Bonilla</surname> <given-names>WV</given-names></name><name><surname>Fröhlich</surname> <given-names>A</given-names></name><name><surname>Helmstetter</surname> <given-names>C</given-names></name><name><surname>Peine</surname> <given-names>M</given-names></name><name><surname>Hegazy</surname> <given-names>AN</given-names></name><name><surname>Pinschewer</surname> <given-names>DD</given-names></name><name><surname>Löhning</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses</article-title><source>PNAS</source><volume>112</volume><fpage>4056</fpage><lpage>4061</lpage><pub-id pub-id-type="doi">10.1073/pnas.1418549112</pub-id><pub-id pub-id-type="pmid">25829541</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonilla</surname> <given-names>WV</given-names></name><name><surname>Fröhlich</surname> <given-names>A</given-names></name><name><surname>Fallon</surname> <given-names>PG</given-names></name><name><surname>Kallert</surname> <given-names>S</given-names></name><name><surname>Fernandez</surname> <given-names>M</given-names></name><name><surname>Johnson</surname> <given-names>S</given-names></name><name><surname>Kreutzfeldt</surname> <given-names>M</given-names></name><name><surname>Hegazy</surname> <given-names>AN</given-names></name><name><surname>Schrick</surname> <given-names>C</given-names></name><name><surname>Senn</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title> The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses</article-title><source>Science</source><volume>335</volume><fpage>984</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1126/science.1215418</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buscher</surname> <given-names>K</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Striewski</surname> <given-names>P</given-names></name><name><surname>Wirth</surname> <given-names>B</given-names></name><name><surname>Saggu</surname> <given-names>G</given-names></name><name><surname>Lütke-Enking</surname> <given-names>S</given-names></name><name><surname>Mayadas</surname> <given-names>TN</given-names></name><name><surname>Ley</surname> <given-names>K</given-names></name><name><surname>Sorokin</surname> <given-names>L</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Protection from septic peritonitis by rapid neutrophil recruitment through omental high endothelial venules</article-title><source>Nature Communications</source><volume>7</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/ncomms10828</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>G</given-names></name><name><surname>Kastelein</surname> <given-names>R</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii</article-title><source>Infection and Immunity</source><volume>68</volume><fpage>6932</fpage><lpage>6938</lpage><pub-id pub-id-type="doi">10.1128/iai.68.12.6932-6938.2000</pub-id><pub-id pub-id-type="pmid">11083816</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>WY</given-names></name><name><surname>Hong</surname> <given-names>J</given-names></name><name><surname>Gannon</surname> <given-names>J</given-names></name><name><surname>Kakkar</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33</article-title><source>PNAS</source><volume>112</volume><fpage>7249</fpage><lpage>7254</lpage><pub-id pub-id-type="doi">10.1073/pnas.1424236112</pub-id><pub-id pub-id-type="pmid">25941360</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Christian</surname> <given-names>DA</given-names></name><name><surname>Kochanowsky</surname> <given-names>JA</given-names></name><name><surname>Phan</surname> <given-names>AT</given-names></name><name><surname>Clark</surname> <given-names>JT</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Berry</surname> <given-names>C</given-names></name><name><surname>Oh</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Roos</surname> <given-names>DS</given-names></name><name><surname>Beiting</surname> <given-names>DP</given-names></name><name><surname>Koshy</surname> <given-names>AA</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Toxoplasma gondii virulence factor ROP16 acts in Cis and Trans, and suppresses T cell responses</article-title><source>Journal of Experimental Medicine</source><volume>217</volume><elocation-id>e20181757</elocation-id><pub-id pub-id-type="doi">10.1084/jem.20181757</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Christian</surname> <given-names>DA</given-names></name><name><surname>Adams</surname> <given-names>TA</given-names></name><name><surname>Shallberg</surname> <given-names>LA</given-names></name><name><surname>Derek</surname> <given-names>J</given-names></name><name><surname>Phan</surname> <given-names>AT</given-names></name><name><surname>Abraha</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>J</given-names></name><name><surname>Ruthel</surname> <given-names>G</given-names></name><name><surname>Clark</surname> <given-names>JT</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name><name><surname>Kedl</surname> <given-names>RM</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>cDC1 coordinate innate and adaptive responses in the omentum required for T cell priming and memory</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.07.21.214809</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>ES</given-names></name><name><surname>Scott</surname> <given-names>IC</given-names></name><name><surname>Majithiya</surname> <given-names>JB</given-names></name><name><surname>Rapley</surname> <given-names>L</given-names></name><name><surname>Kemp</surname> <given-names>BP</given-names></name><name><surname>England</surname> <given-names>E</given-names></name><name><surname>Rees</surname> <given-names>DG</given-names></name><name><surname>Overed-Sayer</surname> <given-names>CL</given-names></name><name><surname>Woods</surname> <given-names>J</given-names></name><name><surname>Bond</surname> <given-names>NJ</given-names></name><name><surname>Veyssier</surname> <given-names>CS</given-names></name><name><surname>Embrey</surname> <given-names>KJ</given-names></name><name><surname>Sims</surname> <given-names>DA</given-names></name><name><surname>Snaith</surname> <given-names>MR</given-names></name><name><surname>Vousden</surname> <given-names>KA</given-names></name><name><surname>Strain</surname> <given-names>MD</given-names></name><name><surname>Chan</surname> <given-names>DT</given-names></name><name><surname>Carmen</surname> <given-names>S</given-names></name><name><surname>Huntington</surname> <given-names>CE</given-names></name><name><surname>Flavell</surname> <given-names>L</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Popovic</surname> <given-names>B</given-names></name><name><surname>Brightling</surname> <given-names>CE</given-names></name><name><surname>Vaughan</surname> <given-names>TJ</given-names></name><name><surname>Butler</surname> <given-names>R</given-names></name><name><surname>Lowe</surname> <given-names>DC</given-names></name><name><surname>Higazi</surname> <given-names>DR</given-names></name><name><surname>Corkill</surname> <given-names>DJ</given-names></name><name><surname>May</surname> <given-names>RD</given-names></name><name><surname>Sleeman</surname> <given-names>MA</given-names></name><name><surname>Mustelin</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8327</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9327</pub-id><pub-id pub-id-type="pmid">26365875</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Rio</surname> <given-names>L</given-names></name><name><surname>Butcher</surname> <given-names>BA</given-names></name><name><surname>Bennouna</surname> <given-names>S</given-names></name><name><surname>Hieny</surname> <given-names>S</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name><name><surname>Denkers</surname> <given-names>EY</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>Toxoplasma gondii</italic> triggers myeloid differentiation factor 88-dependent IL-12 and chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct parasite molecules and host receptors</article-title><source>Journal of Immunology</source><volume>172</volume><fpage>6954</fpage><lpage>6960</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.11.6954</pub-id><pub-id pub-id-type="pmid">15153515</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLaney</surname> <given-names>AA</given-names></name><name><surname>Berry</surname> <given-names>CT</given-names></name><name><surname>Christian</surname> <given-names>DA</given-names></name><name><surname>Hart</surname> <given-names>A</given-names></name><name><surname>Bjanes</surname> <given-names>E</given-names></name><name><surname>Wynosky-Dolfi</surname> <given-names>MA</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Tummers</surname> <given-names>B</given-names></name><name><surname>Udalova</surname> <given-names>IA</given-names></name><name><surname>Chen</surname> <given-names>YH</given-names></name><name><surname>Hershberg</surname> <given-names>U</given-names></name><name><surname>Freedman</surname> <given-names>BD</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Brodsky</surname> <given-names>IE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Caspase-8 promotes c-Rel–dependent inflammatory cytokine expression and resistance against <italic>Toxoplasma gondii</italic></article-title><source>PNAS</source><volume>116</volume><fpage>11926</fpage><lpage>11935</lpage><pub-id pub-id-type="doi">10.1073/pnas.1820529116</pub-id><pub-id pub-id-type="pmid">31147458</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado Betancourt</surname> <given-names>E</given-names></name><name><surname>Hamid</surname> <given-names>B</given-names></name><name><surname>Fabian</surname> <given-names>BT</given-names></name><name><surname>Klotz</surname> <given-names>C</given-names></name><name><surname>Hartmann</surname> <given-names>S</given-names></name><name><surname>Seeber</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>From entry to early Dissemination-<italic>Toxoplasma gondii's</italic> Initial Encounter With Its Host</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>9</volume><elocation-id>46</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2019.00046</pub-id><pub-id pub-id-type="pmid">30891433</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Introduction to the interleukin-1 family of cytokines and receptors: drivers of innate inflammation and acquired immunity</article-title><source>Immunological Reviews</source><volume>281</volume><fpage>5</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/imr.12624</pub-id><pub-id pub-id-type="pmid">29248001</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunay</surname> <given-names>IR</given-names></name><name><surname>Fuchs</surname> <given-names>A</given-names></name><name><surname>Sibley</surname> <given-names>LD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice</article-title><source>Infection and Immunity</source><volume>78</volume><fpage>1564</fpage><lpage>1570</lpage><pub-id pub-id-type="doi">10.1128/IAI.00472-09</pub-id><pub-id pub-id-type="pmid">20145099</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewald</surname> <given-names>SE</given-names></name><name><surname>Chavarria-Smith</surname> <given-names>J</given-names></name><name><surname>Boothroyd</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>NLRP1 is an inflammasome sensor for Toxoplasma gondii</article-title><source>Infection and Immunity</source><volume>82</volume><fpage>460</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1128/IAI.01170-13</pub-id><pub-id pub-id-type="pmid">24218483</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname> <given-names>BA</given-names></name><name><surname>Bzik</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii</article-title><source>Nature</source><volume>415</volume><fpage>926</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1038/415926a</pub-id><pub-id pub-id-type="pmid">11859373</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franca</surname> <given-names>RF</given-names></name><name><surname>Costa</surname> <given-names>RS</given-names></name><name><surname>Silva</surname> <given-names>JR</given-names></name><name><surname>Peres</surname> <given-names>RS</given-names></name><name><surname>Mendonça</surname> <given-names>LR</given-names></name><name><surname>Colón</surname> <given-names>DF</given-names></name><name><surname>Alves-Filho</surname> <given-names>JC</given-names></name><name><surname>Cunha</surname> <given-names>FQ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system</article-title><source>Journal of Neuroinflammation</source><volume>13</volume><elocation-id>159</elocation-id><pub-id pub-id-type="doi">10.1186/s12974-016-0628-1</pub-id><pub-id pub-id-type="pmid">27334012</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuta</surname> <given-names>T</given-names></name><name><surname>Kikuchi</surname> <given-names>T</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name><name><surname>Watanabe</surname> <given-names>N</given-names></name><name><surname>Yoshikawa</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis</article-title><source>International Immunology</source><volume>18</volume><fpage>1655</fpage><lpage>1662</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxl099</pub-id><pub-id pub-id-type="pmid">17035347</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazzinelli</surname> <given-names>RT</given-names></name><name><surname>Hieny</surname> <given-names>S</given-names></name><name><surname>Wynn</surname> <given-names>TA</given-names></name><name><surname>Wolf</surname> <given-names>S</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts</article-title><source>PNAS</source><volume>90</volume><fpage>6115</fpage><lpage>6119</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.13.6115</pub-id><pub-id pub-id-type="pmid">8100999</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Qiu</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Cui</surname> <given-names>L</given-names></name><name><surname>Qi</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>Shi</surname> <given-names>Z</given-names></name><name><surname>Lun</surname> <given-names>Z</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with <italic>Toxoplasma gondii</italic></article-title><source>International Journal for Parasitology</source><volume>44</volume><fpage>475</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2014.03.004</pub-id><pub-id pub-id-type="pmid">24727091</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorfu</surname> <given-names>G</given-names></name><name><surname>Cirelli</surname> <given-names>KM</given-names></name><name><surname>Melo</surname> <given-names>MB</given-names></name><name><surname>Mayer-Barber</surname> <given-names>K</given-names></name><name><surname>Crown</surname> <given-names>D</given-names></name><name><surname>Koller</surname> <given-names>BH</given-names></name><name><surname>Masters</surname> <given-names>S</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name><name><surname>Leppla</surname> <given-names>SH</given-names></name><name><surname>Moayeri</surname> <given-names>M</given-names></name><name><surname>Saeij</surname> <given-names>JP</given-names></name><name><surname>Grigg</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii</article-title><source>mBio</source><volume>5</volume><elocation-id>e01117-13</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01117-13</pub-id><pub-id pub-id-type="pmid">24549849</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname> <given-names>WE</given-names></name><name><surname>Sharma</surname> <given-names>SD</given-names></name><name><surname>Remington</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii</article-title><source>The Journal of Immunology</source><volume>131</volume><fpage>458</fpage><lpage>463</lpage></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hitziger</surname> <given-names>N</given-names></name><name><surname>Dellacasa</surname> <given-names>I</given-names></name><name><surname>Albiger</surname> <given-names>B</given-names></name><name><surname>Barragan</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dissemination of Toxoplasma gondii to immunoprivileged organs and role of toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging</article-title><source>Cellular Microbiology</source><volume>7</volume><fpage>837</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00517.x</pub-id><pub-id pub-id-type="pmid">15888086</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphreys</surname> <given-names>NE</given-names></name><name><surname>Xu</surname> <given-names>D</given-names></name><name><surname>Hepworth</surname> <given-names>MR</given-names></name><name><surname>Liew</surname> <given-names>FY</given-names></name><name><surname>Grencis</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>IL-33, a potent inducer of adaptive immunity to intestinal Nematodes</article-title><source>The Journal of Immunology</source><volume>180</volume><fpage>2443</fpage><lpage>2449</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.4.2443</pub-id><pub-id pub-id-type="pmid">18250453</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Abrams</surname> <given-names>JS</given-names></name><name><surname>Beaman</surname> <given-names>MH</given-names></name><name><surname>Remington</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii</article-title><source>Infection and Immunity</source><volume>61</volume><fpage>4038</fpage><lpage>4044</lpage><pub-id pub-id-type="doi">10.1128/IAI.61.10.4038-4044.1993</pub-id><pub-id pub-id-type="pmid">8406791</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Subauste</surname> <given-names>CS</given-names></name><name><surname>Van Cleave</surname> <given-names>VH</given-names></name><name><surname>Remington</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha</article-title><source>Infection and Immunity</source><volume>62</volume><fpage>2818</fpage><lpage>2824</lpage><pub-id pub-id-type="doi">10.1128/IAI.62.7.2818-2824.1994</pub-id><pub-id pub-id-type="pmid">7911785</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Chizzonite</surname> <given-names>R</given-names></name><name><surname>Remington</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1995">1995a</year><article-title>IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens</article-title><source>Journal of Immunology</source><volume>155</volume><fpage>4347</fpage><lpage>4354</lpage></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Candolfi</surname> <given-names>E</given-names></name><name><surname>Subauste</surname> <given-names>C</given-names></name><name><surname>Van Cleave</surname> <given-names>V</given-names></name><name><surname>Remington</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1995">1995b</year><article-title>Studies on the role of interleukin-12 in acute murine toxoplasmosis</article-title><source>Immunology</source><volume>84</volume><fpage>16</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">7890300</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Ellis-Neyer</surname> <given-names>L</given-names></name><name><surname>Gabriel</surname> <given-names>KE</given-names></name><name><surname>Kennedy</surname> <given-names>MK</given-names></name><name><surname>Grabstein</surname> <given-names>KH</given-names></name><name><surname>Linsley</surname> <given-names>PS</given-names></name><name><surname>Remington</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii</article-title><source>Journal of Immunology</source><volume>158</volume><fpage>2285</fpage><lpage>2293</lpage></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israelski</surname> <given-names>DM</given-names></name><name><surname>Remington</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Toxoplasmic encephalitis in patients with AIDS</article-title><source>Infectious Disease Clinics of North America</source><volume>2</volume><fpage>429</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/S0891-5520(20)30196-3</pub-id><pub-id pub-id-type="pmid">3060527</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>M</given-names></name><name><surname>Komai</surname> <given-names>K</given-names></name><name><surname>Mise-Omata</surname> <given-names>S</given-names></name><name><surname>Iizuka-Koga</surname> <given-names>M</given-names></name><name><surname>Noguchi</surname> <given-names>Y</given-names></name><name><surname>Kondo</surname> <given-names>T</given-names></name><name><surname>Sakai</surname> <given-names>R</given-names></name><name><surname>Matsuo</surname> <given-names>K</given-names></name><name><surname>Nakayama</surname> <given-names>T</given-names></name><name><surname>Yoshie</surname> <given-names>O</given-names></name><name><surname>Nakatsukasa</surname> <given-names>H</given-names></name><name><surname>Chikuma</surname> <given-names>S</given-names></name><name><surname>Shichita</surname> <given-names>T</given-names></name><name><surname>Yoshimura</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery</article-title><source>Nature</source><volume>565</volume><fpage>246</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0824-5</pub-id><pub-id pub-id-type="pmid">30602786</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson-Jones</surname> <given-names>LH</given-names></name><name><surname>Duncan</surname> <given-names>SM</given-names></name><name><surname>Magalhaes</surname> <given-names>MS</given-names></name><name><surname>Campbell</surname> <given-names>SM</given-names></name><name><surname>Maizels</surname> <given-names>RM</given-names></name><name><surname>McSorley</surname> <given-names>HJ</given-names></name><name><surname>Allen</surname> <given-names>JE</given-names></name><name><surname>Bénézech</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12651</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12651</pub-id><pub-id pub-id-type="pmid">27582256</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname> <given-names>B</given-names></name><name><surname>Harris</surname> <given-names>TH</given-names></name><name><surname>Tait</surname> <given-names>ED</given-names></name><name><surname>Wilson</surname> <given-names>EH</given-names></name><name><surname>Gregg</surname> <given-names>B</given-names></name><name><surname>Ng</surname> <given-names>LG</given-names></name><name><surname>Mrass</surname> <given-names>P</given-names></name><name><surname>Roos</surname> <given-names>DS</given-names></name><name><surname>Dzierszinski</surname> <given-names>F</given-names></name><name><surname>Weninger</surname> <given-names>W</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dynamic imaging of CD8(+) T cells and dendritic cells during infection with <italic>Toxoplasma gondii</italic></article-title><source>PLOS Pathogens</source><volume>5</volume><elocation-id>e1000505</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000505</pub-id><pub-id pub-id-type="pmid">19578440</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname> <given-names>LK</given-names></name><name><surname>Hsu</surname> <given-names>CL</given-names></name><name><surname>Krier-Burris</surname> <given-names>RA</given-names></name><name><surname>Chhiba</surname> <given-names>KD</given-names></name><name><surname>Chien</surname> <given-names>KB</given-names></name><name><surname>McKenzie</surname> <given-names>A</given-names></name><name><surname>Berdnikovs</surname> <given-names>S</given-names></name><name><surname>Bryce</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>IL-33 precedes IL-5 in regulating eosinophil commitment and is required for eosinophil homeostasis</article-title><source>The Journal of Immunology</source><volume>197</volume><fpage>3445</fpage><lpage>3453</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600611</pub-id><pub-id pub-id-type="pmid">27683753</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>LA</given-names></name><name><surname>Roberts</surname> <given-names>F</given-names></name><name><surname>Nickdel</surname> <given-names>MB</given-names></name><name><surname>Brombacher</surname> <given-names>F</given-names></name><name><surname>McKenzie</surname> <given-names>AN</given-names></name><name><surname>Henriquez</surname> <given-names>FL</given-names></name><name><surname>Alexander</surname> <given-names>J</given-names></name><name><surname>Roberts</surname> <given-names>CW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii</article-title><source>European Journal of Immunology</source><volume>40</volume><fpage>426</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1002/eji.200939705</pub-id><pub-id pub-id-type="pmid">19950183</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname> <given-names>CH</given-names></name><name><surname>Chockalingam</surname> <given-names>A</given-names></name><name><surname>Leifer</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Early response of mucosal epithelial cells during Toxoplasma gondii infection</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>7420</fpage><lpage>7427</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900640</pub-id><pub-id pub-id-type="pmid">19917706</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakkar</surname> <given-names>R</given-names></name><name><surname>Hei</surname> <given-names>H</given-names></name><name><surname>Dobner</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>RT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Interleukin 33 as a mechanically responsive cytokine secreted by living cells</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>6941</fpage><lpage>6948</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.298703</pub-id><pub-id pub-id-type="pmid">22215666</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearley</surname> <given-names>J</given-names></name><name><surname>Silver</surname> <given-names>JS</given-names></name><name><surname>Sanden</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Berlin</surname> <given-names>AA</given-names></name><name><surname>White</surname> <given-names>N</given-names></name><name><surname>Mori</surname> <given-names>M</given-names></name><name><surname>Pham</surname> <given-names>TH</given-names></name><name><surname>Ward</surname> <given-names>CK</given-names></name><name><surname>Criner</surname> <given-names>GJ</given-names></name><name><surname>Marchetti</surname> <given-names>N</given-names></name><name><surname>Mustelin</surname> <given-names>T</given-names></name><name><surname>Erjefalt</surname> <given-names>JS</given-names></name><name><surname>Kolbeck</surname> <given-names>R</given-names></name><name><surname>Humbles</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection</article-title><source>Immunity</source><volume>42</volume><fpage>566</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.02.011</pub-id><pub-id pub-id-type="pmid">25786179</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>IA</given-names></name><name><surname>Matsuura</surname> <given-names>T</given-names></name><name><surname>Kasper</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Interleukin-12 enhances murine survival against acute toxoplasmosis</article-title><source>Infection and Immunity</source><volume>62</volume><fpage>1639</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1128/IAI.62.5.1639-1642.1994</pub-id><pub-id pub-id-type="pmid">7909536</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>L</given-names></name><name><surname>Butcher</surname> <given-names>BA</given-names></name><name><surname>Lee</surname> <given-names>CW</given-names></name><name><surname>Uematsu</surname> <given-names>S</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name><name><surname>Denkers</surname> <given-names>EY</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Toxoplasma gondii genotype determines MyD88-dependent signaling in infected macrophages</article-title><source>The Journal of Immunology</source><volume>177</volume><fpage>2584</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.4.2584</pub-id><pub-id pub-id-type="pmid">16888020</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname> <given-names>CS</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis</article-title><source>Nature Immunology</source><volume>17</volume><fpage>765</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1038/ni.3489</pub-id><pub-id pub-id-type="pmid">27328006</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konradt</surname> <given-names>C</given-names></name><name><surname>Ueno</surname> <given-names>N</given-names></name><name><surname>Christian</surname> <given-names>DA</given-names></name><name><surname>Delong</surname> <given-names>JH</given-names></name><name><surname>Pritchard</surname> <given-names>GH</given-names></name><name><surname>Herz</surname> <given-names>J</given-names></name><name><surname>Bzik</surname> <given-names>DJ</given-names></name><name><surname>Koshy</surname> <given-names>AA</given-names></name><name><surname>McGavern</surname> <given-names>DB</given-names></name><name><surname>Lodoen</surname> <given-names>MB</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system</article-title><source>Nature Microbiology</source><volume>1</volume><elocation-id>16001</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.1</pub-id><pub-id pub-id-type="pmid">27572166</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouzaki</surname> <given-names>H</given-names></name><name><surname>Iijima</surname> <given-names>K</given-names></name><name><surname>Kobayashi</surname> <given-names>T</given-names></name><name><surname>O'Grady</surname> <given-names>SM</given-names></name><name><surname>Kita</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses</article-title><source>The Journal of Immunology</source><volume>186</volume><fpage>4375</fpage><lpage>4387</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003020</pub-id><pub-id pub-id-type="pmid">21357533</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaRosa</surname> <given-names>DF</given-names></name><name><surname>Stumhofer</surname> <given-names>JS</given-names></name><name><surname>Gelman</surname> <given-names>AE</given-names></name><name><surname>Rahman</surname> <given-names>AH</given-names></name><name><surname>Taylor</surname> <given-names>DK</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Turka</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>T cell expression of MyD88 is required for resistance to Toxoplasma gondii</article-title><source>PNAS</source><volume>105</volume><fpage>3855</fpage><lpage>3860</lpage><pub-id pub-id-type="doi">10.1073/pnas.0706663105</pub-id><pub-id pub-id-type="pmid">18308927</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Jiang</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Ji</surname> <given-names>S</given-names></name><name><surname>Xiao</surname> <given-names>S</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name><name><surname>Radek</surname> <given-names>KA</given-names></name><name><surname>Xia</surname> <given-names>Z</given-names></name><name><surname>Lai</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1003918</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003918</pub-id><pub-id pub-id-type="pmid">24586149</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liew</surname> <given-names>FY</given-names></name><name><surname>Girard</surname> <given-names>JP</given-names></name><name><surname>Turnquist</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interleukin-33 in health and disease</article-title><source>Nature Reviews Immunology</source><volume>16</volume><fpage>676</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.95</pub-id><pub-id pub-id-type="pmid">27640624</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname> <given-names>TS</given-names></name><name><surname>Gov</surname> <given-names>L</given-names></name><name><surname>Lodoen</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Evasion of human Neutrophil-Mediated host defense during <italic>Toxoplasma gondii</italic> Infection</article-title><source>mBio</source><volume>9</volume><elocation-id>e02027-17</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02027-17</pub-id><pub-id pub-id-type="pmid">29440572</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Zou</surname> <given-names>X</given-names></name><name><surname>Ou</surname> <given-names>M</given-names></name><name><surname>Ye</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Wu</surname> <given-names>T</given-names></name><name><surname>Dong</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Zheng</surname> <given-names>Z</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Wen</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>S</given-names></name><name><surname>Zhu</surname> <given-names>K</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Du</surname> <given-names>X</given-names></name><name><surname>Liang</surname> <given-names>J</given-names></name><name><surname>Luo</surname> <given-names>X</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>C</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>K</given-names></name><name><surname>Yuting</surname> <given-names>Y</given-names></name><name><surname>Qi</surname> <given-names>G</given-names></name><name><surname>Jing</surname> <given-names>C</given-names></name><name><surname>Yang</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Toxoplasma gondii cathepsin C1 inhibits NF-κB signalling through the positive regulation of the HIF-1α/EPO Axis</article-title><source>Acta Tropica</source><volume>195</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.actatropica.2019.04.018</pub-id><pub-id pub-id-type="pmid">31004564</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llop-Guevara</surname> <given-names>A</given-names></name><name><surname>Chu</surname> <given-names>DK</given-names></name><name><surname>Walker</surname> <given-names>TD</given-names></name><name><surname>Goncharova</surname> <given-names>S</given-names></name><name><surname>Fattouh</surname> <given-names>R</given-names></name><name><surname>Silver</surname> <given-names>JS</given-names></name><name><surname>Moore</surname> <given-names>CL</given-names></name><name><surname>Xie</surname> <given-names>JL</given-names></name><name><surname>O'Byrne</surname> <given-names>PM</given-names></name><name><surname>Coyle</surname> <given-names>AJ</given-names></name><name><surname>Kolbeck</surname> <given-names>R</given-names></name><name><surname>Humbles</surname> <given-names>AA</given-names></name><name><surname>Stämpfli</surname> <given-names>MR</given-names></name><name><surname>Jordana</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A GM-CSF/IL-33 pathway facilitates allergic airway responses to sub-threshold house dust mite exposure</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e88714</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0088714</pub-id><pub-id pub-id-type="pmid">24551140</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>López-Yglesias</surname> <given-names>AH</given-names></name><name><surname>Burger</surname> <given-names>E</given-names></name><name><surname>Camanzo</surname> <given-names>E</given-names></name><name><surname>Martin</surname> <given-names>AT</given-names></name><name><surname>Araujo</surname> <given-names>AM</given-names></name><name><surname>Kwok</surname> <given-names>SF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ILC1-derived IFN-γ mediates cDC1-dependent host resistance against <italic>Toxoplasma gondii</italic></article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.01.06.895771</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu</surname> <given-names>L</given-names></name><name><surname>Johnston</surname> <given-names>LJ</given-names></name><name><surname>Derricott</surname> <given-names>H</given-names></name><name><surname>Armstrong</surname> <given-names>SD</given-names></name><name><surname>Randle</surname> <given-names>N</given-names></name><name><surname>Hartley</surname> <given-names>CS</given-names></name><name><surname>Duckworth</surname> <given-names>CA</given-names></name><name><surname>Campbell</surname> <given-names>BJ</given-names></name><name><surname>Wastling</surname> <given-names>JM</given-names></name><name><surname>Coombes</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An Open-Format enteroid culture system for interrogation of interactions between <italic>Toxoplasma gondii</italic> and the Intestinal Epithelium</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>9</volume><elocation-id>300</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2019.00300</pub-id><pub-id pub-id-type="pmid">31555604</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname> <given-names>SM</given-names></name><name><surname>Kanneganti</surname> <given-names>TD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of inflammasome activation</article-title><source>Immunological Reviews</source><volume>265</volume><fpage>6</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1111/imr.12296</pub-id><pub-id pub-id-type="pmid">25879280</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matta</surname> <given-names>BM</given-names></name><name><surname>Lott</surname> <given-names>JM</given-names></name><name><surname>Mathews</surname> <given-names>LR</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Rosborough</surname> <given-names>BR</given-names></name><name><surname>Blazar</surname> <given-names>BR</given-names></name><name><surname>Turnquist</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells</article-title><source>The Journal of Immunology</source><volume>193</volume><fpage>4010</fpage><lpage>4020</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1400481</pub-id><pub-id pub-id-type="pmid">25217167</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melchor</surname> <given-names>SJ</given-names></name><name><surname>Saunders</surname> <given-names>CM</given-names></name><name><surname>Sanders</surname> <given-names>I</given-names></name><name><surname>Hatter</surname> <given-names>JA</given-names></name><name><surname>Byrnes</surname> <given-names>KA</given-names></name><name><surname>Coutermarsh-Ott</surname> <given-names>S</given-names></name><name><surname>Ewald</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IL-1R regulates disease tolerance and cachexia in <italic>Toxoplasma gondii</italic> Infection</article-title><source>The Journal of Immunology</source><volume>204</volume><fpage>3329</fpage><lpage>3338</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.2000159</pub-id><pub-id pub-id-type="pmid">32350081</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercer</surname> <given-names>HL</given-names></name><name><surname>Snyder</surname> <given-names>LM</given-names></name><name><surname>Doherty</surname> <given-names>CM</given-names></name><name><surname>Fox</surname> <given-names>BA</given-names></name><name><surname>Bzik</surname> <given-names>DJ</given-names></name><name><surname>Denkers</surname> <given-names>EY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Toxoplasma gondii dense granule protein GRA24 drives MyD88-independent p38 MAPK activation, IL-12 production and induction of protective immunity</article-title><source>PLOS Pathogens</source><volume>16</volume><elocation-id>e1008572</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008572</pub-id><pub-id pub-id-type="pmid">32413093</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milovanovic</surname> <given-names>M</given-names></name><name><surname>Volarevic</surname> <given-names>V</given-names></name><name><surname>Ljujic</surname> <given-names>B</given-names></name><name><surname>Radosavljevic</surname> <given-names>G</given-names></name><name><surname>Jovanovic</surname> <given-names>I</given-names></name><name><surname>Arsenijevic</surname> <given-names>N</given-names></name><name><surname>Lukic</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e45225</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0045225</pub-id><pub-id pub-id-type="pmid">23028861</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molofsky</surname> <given-names>AB</given-names></name><name><surname>Savage</surname> <given-names>AK</given-names></name><name><surname>Locksley</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interleukin-33 in tissue homeostasis, injury, and inflammation</article-title><source>Immunity</source><volume>42</volume><fpage>1005</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.006</pub-id><pub-id pub-id-type="pmid">26084021</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monticelli</surname> <given-names>LA</given-names></name><name><surname>Sonnenberg</surname> <given-names>GF</given-names></name><name><surname>Abt</surname> <given-names>MC</given-names></name><name><surname>Alenghat</surname> <given-names>T</given-names></name><name><surname>Ziegler</surname> <given-names>CGK</given-names></name><name><surname>Doering</surname> <given-names>TA</given-names></name><name><surname>Angelosanto</surname> <given-names>JM</given-names></name><name><surname>Laidlaw</surname> <given-names>BJ</given-names></name><name><surname>Yang</surname> <given-names>CY</given-names></name><name><surname>Sathaliyawala</surname> <given-names>T</given-names></name><name><surname>Kubota</surname> <given-names>M</given-names></name><name><surname>Turner</surname> <given-names>D</given-names></name><name><surname>Diamond</surname> <given-names>JM</given-names></name><name><surname>Goldrath</surname> <given-names>AW</given-names></name><name><surname>Farber</surname> <given-names>DL</given-names></name><name><surname>Collman</surname> <given-names>RG</given-names></name><name><surname>Wherry</surname> <given-names>EJ</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus</article-title><source>Nature Immunology</source><volume>12</volume><fpage>1045</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1038/ni.2131</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monticelli</surname> <given-names>LA</given-names></name><name><surname>Osborne</surname> <given-names>LC</given-names></name><name><surname>Noti</surname> <given-names>M</given-names></name><name><surname>Tran</surname> <given-names>SV</given-names></name><name><surname>Zaiss</surname> <given-names>DMW</given-names></name><name><surname>Artis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin–EGFR interactions</article-title><source>PNAS</source><volume>112</volume><fpage>10762</fpage><lpage>10767</lpage><pub-id pub-id-type="doi">10.1073/pnas.1509070112</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montoya</surname> <given-names>JG</given-names></name><name><surname>Liesenfeld</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Toxoplasmosis</article-title><source>The Lancet</source><volume>363</volume><fpage>1965</fpage><lpage>1976</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)16412-X</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mordue</surname> <given-names>DG</given-names></name><name><surname>Monroy</surname> <given-names>F</given-names></name><name><surname>La Regina</surname> <given-names>M</given-names></name><name><surname>Dinarello</surname> <given-names>CA</given-names></name><name><surname>Sibley</surname> <given-names>LD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines</article-title><source>The Journal of Immunology</source><volume>167</volume><fpage>4574</fpage><lpage>4584</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.8.4574</pub-id><pub-id pub-id-type="pmid">11591786</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moussion</surname> <given-names>C</given-names></name><name><surname>Ortega</surname> <given-names>N</given-names></name><name><surname>Girard</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e3331</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0003331</pub-id><pub-id pub-id-type="pmid">18836528</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muñoz</surname> <given-names>M</given-names></name><name><surname>Eidenschenk</surname> <given-names>C</given-names></name><name><surname>Ota</surname> <given-names>N</given-names></name><name><surname>Wong</surname> <given-names>K</given-names></name><name><surname>Lohmann</surname> <given-names>U</given-names></name><name><surname>Kühl</surname> <given-names>AA</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Manzanillo</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Rutz</surname> <given-names>S</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Diehl</surname> <given-names>L</given-names></name><name><surname>Kayagaki</surname> <given-names>N</given-names></name><name><surname>van Lookeren-Campagne</surname> <given-names>M</given-names></name><name><surname>Liesenfeld</surname> <given-names>O</given-names></name><name><surname>Heimesaat</surname> <given-names>M</given-names></name><name><surname>Ouyang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection</article-title><source>Immunity</source><volume>42</volume><fpage>321</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.01.011</pub-id><pub-id pub-id-type="pmid">25680273</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabekura</surname> <given-names>T</given-names></name><name><surname>Girard</surname> <given-names>J-P</given-names></name><name><surname>Lanier</surname> <given-names>LL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse Cytomegalovirus infection</article-title><source>The Journal of Immunology</source><volume>194</volume><fpage>5948</fpage><lpage>5952</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500424</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osbourn</surname> <given-names>M</given-names></name><name><surname>Soares</surname> <given-names>DC</given-names></name><name><surname>Vacca</surname> <given-names>F</given-names></name><name><surname>Cohen</surname> <given-names>ES</given-names></name><name><surname>Scott</surname> <given-names>IC</given-names></name><name><surname>Gregory</surname> <given-names>WF</given-names></name><name><surname>Smyth</surname> <given-names>DJ</given-names></name><name><surname>Toivakka</surname> <given-names>M</given-names></name><name><surname>Kemter</surname> <given-names>AM</given-names></name><name><surname>le Bihan</surname> <given-names>T</given-names></name><name><surname>Wear</surname> <given-names>M</given-names></name><name><surname>Hoving</surname> <given-names>D</given-names></name><name><surname>Filbey</surname> <given-names>KJ</given-names></name><name><surname>Hewitson</surname> <given-names>JP</given-names></name><name><surname>Henderson</surname> <given-names>H</given-names></name><name><surname>Gonzàlez-Cìscar</surname> <given-names>A</given-names></name><name><surname>Errington</surname> <given-names>C</given-names></name><name><surname>Vermeren</surname> <given-names>S</given-names></name><name><surname>Astier</surname> <given-names>AL</given-names></name><name><surname>Wallace</surname> <given-names>WA</given-names></name><name><surname>Schwarze</surname> <given-names>J</given-names></name><name><surname>Ivens</surname> <given-names>AC</given-names></name><name><surname>Maizels</surname> <given-names>RM</given-names></name><name><surname>McSorley</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>HpARI protein secreted by a helminth parasite suppresses Interleukin-33</article-title><source>Immunity</source><volume>47</volume><fpage>739</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.09.015</pub-id><pub-id pub-id-type="pmid">29045903</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>E</given-names></name><name><surname>Patel</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Andhey</surname> <given-names>P</given-names></name><name><surname>Zaitsev</surname> <given-names>K</given-names></name><name><surname>Porter</surname> <given-names>S</given-names></name><name><surname>Hershey</surname> <given-names>M</given-names></name><name><surname>Bern</surname> <given-names>M</given-names></name><name><surname>Plougastel-Douglas</surname> <given-names>B</given-names></name><name><surname>Collins</surname> <given-names>P</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name><name><surname>Murphy</surname> <given-names>KM</given-names></name><name><surname>Oltz</surname> <given-names>E</given-names></name><name><surname>Artyomov</surname> <given-names>M</given-names></name><name><surname>Sibley</surname> <given-names>LD</given-names></name><name><surname>Yokoyama</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Toxoplasma gondii</italic> infection drives conversion of NK cells into ILC1-like cells</article-title><source>eLife</source><volume>8</volume><elocation-id>e47605</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.47605</pub-id><pub-id pub-id-type="pmid">31393266</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plattner</surname> <given-names>F</given-names></name><name><surname>Yarovinsky</surname> <given-names>F</given-names></name><name><surname>Romero</surname> <given-names>S</given-names></name><name><surname>Didry</surname> <given-names>D</given-names></name><name><surname>Carlier</surname> <given-names>MF</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name><name><surname>Soldati-Favre</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response</article-title><source>Cell Host &amp; Microbe</source><volume>3</volume><fpage>77</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2008.01.001</pub-id><pub-id pub-id-type="pmid">18312842</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname> <given-names>N</given-names></name><name><surname>Walker</surname> <given-names>AW</given-names></name><name><surname>Stolarczyk</surname> <given-names>E</given-names></name><name><surname>Canavan</surname> <given-names>JB</given-names></name><name><surname>Gökmen</surname> <given-names>MR</given-names></name><name><surname>Marks</surname> <given-names>E</given-names></name><name><surname>Jackson</surname> <given-names>I</given-names></name><name><surname>Hashim</surname> <given-names>A</given-names></name><name><surname>Curtis</surname> <given-names>MA</given-names></name><name><surname>Jenner</surname> <given-names>RG</given-names></name><name><surname>Howard</surname> <given-names>JK</given-names></name><name><surname>Parkhill</surname> <given-names>J</given-names></name><name><surname>MacDonald</surname> <given-names>TT</given-names></name><name><surname>Lord</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells</article-title><source>Immunity</source><volume>37</volume><fpage>674</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.008</pub-id><pub-id pub-id-type="pmid">23063332</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reverchon</surname> <given-names>F</given-names></name><name><surname>Mortaud</surname> <given-names>S</given-names></name><name><surname>Sivoyon</surname> <given-names>M</given-names></name><name><surname>Maillet</surname> <given-names>I</given-names></name><name><surname>Laugeray</surname> <given-names>A</given-names></name><name><surname>Palomo</surname> <given-names>J</given-names></name><name><surname>Montécot</surname> <given-names>C</given-names></name><name><surname>Herzine</surname> <given-names>A</given-names></name><name><surname>Meme</surname> <given-names>S</given-names></name><name><surname>Meme</surname> <given-names>W</given-names></name><name><surname>Erard</surname> <given-names>F</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name><name><surname>Menuet</surname> <given-names>A</given-names></name><name><surname>Quesniaux</surname> <given-names>VFJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006322</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006322</pub-id><pub-id pub-id-type="pmid">28448579</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricardo-Gonzalez</surname> <given-names>RR</given-names></name><name><surname>Van Dyken</surname> <given-names>SJ</given-names></name><name><surname>Schneider</surname> <given-names>C</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Nussbaum</surname> <given-names>JC</given-names></name><name><surname>Liang</surname> <given-names>HE</given-names></name><name><surname>Vaka</surname> <given-names>D</given-names></name><name><surname>Eckalbar</surname> <given-names>WL</given-names></name><name><surname>Molofsky</surname> <given-names>AB</given-names></name><name><surname>Erle</surname> <given-names>DJ</given-names></name><name><surname>Locksley</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tissue signals imprint ILC2 identity with anticipatory function</article-title><source>Nature Immunology</source><volume>19</volume><fpage>1093</fpage><lpage>1099</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0201-4</pub-id><pub-id pub-id-type="pmid">30201992</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostan</surname> <given-names>O</given-names></name><name><surname>Gangneux</surname> <given-names>JP</given-names></name><name><surname>Piquet-Pellorce</surname> <given-names>C</given-names></name><name><surname>Manuel</surname> <given-names>C</given-names></name><name><surname>McKenzie</surname> <given-names>AN</given-names></name><name><surname>Guiguen</surname> <given-names>C</given-names></name><name><surname>Samson</surname> <given-names>M</given-names></name><name><surname>Robert-Gangneux</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The IL-33/ST2 Axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with leishmania donovani</article-title><source>mBio</source><volume>4</volume><elocation-id>e00383-13</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00383-13</pub-id><pub-id pub-id-type="pmid">24045639</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostan</surname> <given-names>O</given-names></name><name><surname>Arshad</surname> <given-names>MI</given-names></name><name><surname>Piquet-Pellorce</surname> <given-names>C</given-names></name><name><surname>Robert-Gangneux</surname> <given-names>F</given-names></name><name><surname>Gangneux</surname> <given-names>JP</given-names></name><name><surname>Samson</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Crucial and diverse role of the interleukin-33/ST2 Axis in infectious diseases</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>1738</fpage><lpage>1748</lpage><pub-id pub-id-type="doi">10.1128/IAI.02908-14</pub-id><pub-id pub-id-type="pmid">25712928</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandstrom</surname> <given-names>A</given-names></name><name><surname>Mitchell</surname> <given-names>PS</given-names></name><name><surname>Goers</surname> <given-names>L</given-names></name><name><surname>Mu</surname> <given-names>EW</given-names></name><name><surname>Lesser</surname> <given-names>CF</given-names></name><name><surname>Vance</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Functional degradation: a mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes</article-title><source>Science</source><volume>364</volume><elocation-id>eaau1330</elocation-id><pub-id pub-id-type="doi">10.1126/science.aau1330</pub-id><pub-id pub-id-type="pmid">30872533</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scanga</surname> <given-names>CA</given-names></name><name><surname>Aliberti</surname> <given-names>J</given-names></name><name><surname>Jankovic</surname> <given-names>D</given-names></name><name><surname>Tilloy</surname> <given-names>F</given-names></name><name><surname>Bennouna</surname> <given-names>S</given-names></name><name><surname>Denkers</surname> <given-names>EY</given-names></name><name><surname>Medzhitov</surname> <given-names>R</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cutting edge: myd88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells</article-title><source>The Journal of Immunology</source><volume>168</volume><fpage>5997</fpage><lpage>6001</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.12.5997</pub-id><pub-id pub-id-type="pmid">12055206</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharton-Kersten</surname> <given-names>TM</given-names></name><name><surname>Yap</surname> <given-names>G</given-names></name><name><surname>Magram</surname> <given-names>J</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen <italic>Toxoplasma gondii</italic></article-title><source>Journal of Experimental Medicine</source><volume>185</volume><fpage>1261</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1084/jem.185.7.1261</pub-id><pub-id pub-id-type="pmid">9104813</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiering</surname> <given-names>C</given-names></name><name><surname>Krausgruber</surname> <given-names>T</given-names></name><name><surname>Chomka</surname> <given-names>A</given-names></name><name><surname>Fröhlich</surname> <given-names>A</given-names></name><name><surname>Adelmann</surname> <given-names>K</given-names></name><name><surname>Wohlfert</surname> <given-names>EA</given-names></name><name><surname>Pott</surname> <given-names>J</given-names></name><name><surname>Griseri</surname> <given-names>T</given-names></name><name><surname>Bollrath</surname> <given-names>J</given-names></name><name><surname>Hegazy</surname> <given-names>AN</given-names></name><name><surname>Harrison</surname> <given-names>OJ</given-names></name><name><surname>Owens</surname> <given-names>BMJ</given-names></name><name><surname>Löhning</surname> <given-names>M</given-names></name><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>Fallon</surname> <given-names>PG</given-names></name><name><surname>Powrie</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The alarmin IL-33 promotes regulatory T-cell function in the intestine</article-title><source>Nature</source><volume>513</volume><fpage>564</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1038/nature13577</pub-id><pub-id pub-id-type="pmid">25043027</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname> <given-names>J</given-names></name><name><surname>Owyang</surname> <given-names>A</given-names></name><name><surname>Oldham</surname> <given-names>E</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Murphy</surname> <given-names>E</given-names></name><name><surname>McClanahan</surname> <given-names>TK</given-names></name><name><surname>Zurawski</surname> <given-names>G</given-names></name><name><surname>Moshrefi</surname> <given-names>M</given-names></name><name><surname>Qin</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Gorman</surname> <given-names>DM</given-names></name><name><surname>Bazan</surname> <given-names>JF</given-names></name><name><surname>Kastelein</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines</article-title><source>Immunity</source><volume>23</volume><fpage>479</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2005.09.015</pub-id><pub-id pub-id-type="pmid">16286016</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serbina</surname> <given-names>NV</given-names></name><name><surname>Salazar-Mather</surname> <given-names>TP</given-names></name><name><surname>Biron</surname> <given-names>CA</given-names></name><name><surname>Kuziel</surname> <given-names>WA</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection</article-title><source>Immunity</source><volume>19</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(03)00171-7</pub-id><pub-id pub-id-type="pmid">12871639</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname> <given-names>JS</given-names></name><name><surname>Kearley</surname> <given-names>J</given-names></name><name><surname>Copenhaver</surname> <given-names>AM</given-names></name><name><surname>Sanden</surname> <given-names>C</given-names></name><name><surname>Mori</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Pritchard</surname> <given-names>GH</given-names></name><name><surname>Berlin</surname> <given-names>AA</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Bowler</surname> <given-names>R</given-names></name><name><surname>Erjefalt</surname> <given-names>JS</given-names></name><name><surname>Kolbeck</surname> <given-names>R</given-names></name><name><surname>Humbles</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs</article-title><source>Nature Immunology</source><volume>17</volume><fpage>626</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1038/ni.3443</pub-id><pub-id pub-id-type="pmid">27111143</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snelgrove</surname> <given-names>RJ</given-names></name><name><surname>Gregory</surname> <given-names>LG</given-names></name><name><surname>Peiró</surname> <given-names>T</given-names></name><name><surname>Akthar</surname> <given-names>S</given-names></name><name><surname>Campbell</surname> <given-names>GA</given-names></name><name><surname>Walker</surname> <given-names>SA</given-names></name><name><surname>Lloyd</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations</article-title><source>Journal of Allergy and Clinical Immunology</source><volume>134</volume><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2014.02.002</pub-id><pub-id pub-id-type="pmid">24636086</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spallanzani</surname> <given-names>RG</given-names></name><name><surname>Zemmour</surname> <given-names>D</given-names></name><name><surname>Xiao</surname> <given-names>T</given-names></name><name><surname>Jayewickreme</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Bryce</surname> <given-names>PJ</given-names></name><name><surname>Benoist</surname> <given-names>C</given-names></name><name><surname>Mathis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors</article-title><source>Science Immunology</source><volume>4</volume><elocation-id>eaaw3658</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aaw3658</pub-id><pub-id pub-id-type="pmid">31053654</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Still</surname> <given-names>KM</given-names></name><name><surname>Batista</surname> <given-names>SJ</given-names></name><name><surname>O'Brien</surname> <given-names>CA</given-names></name><name><surname>Oyesola</surname> <given-names>OO</given-names></name><name><surname>Früh</surname> <given-names>SP</given-names></name><name><surname>Webb</surname> <given-names>LM</given-names></name><name><surname>Smirnov</surname> <given-names>I</given-names></name><name><surname>Kovacs</surname> <given-names>MA</given-names></name><name><surname>Cowan</surname> <given-names>MN</given-names></name><name><surname>Hayes</surname> <given-names>NW</given-names></name><name><surname>Thompson</surname> <given-names>JA</given-names></name><name><surname>Tait Wojno</surname> <given-names>ED</given-names></name><name><surname>Harris</surname> <given-names>TH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Astrocytes promote a protective immune response to brain Toxoplasma gondii infection via IL-33-ST2 signaling</article-title><source>PLOS Pathogens</source><volume>16</volume><elocation-id>e1009027</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009027</pub-id><pub-id pub-id-type="pmid">33108405</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Struck</surname> <given-names>D</given-names></name><name><surname>Frank</surname> <given-names>I</given-names></name><name><surname>Enders</surname> <given-names>S</given-names></name><name><surname>Steinhoff</surname> <given-names>U</given-names></name><name><surname>Schmidt</surname> <given-names>C</given-names></name><name><surname>Stallmach</surname> <given-names>A</given-names></name><name><surname>Liesenfeld</surname> <given-names>O</given-names></name><name><surname>Heimesaat</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Treatment with interleukin-18 binding protein ameliorates <italic>Toxoplasma gondii</italic> -induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18</article-title><source>European Journal of Microbiology and Immunology</source><volume>2</volume><fpage>249</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1556/EuJMI.2.2012.3.11</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sukhumavasi</surname> <given-names>W</given-names></name><name><surname>Egan</surname> <given-names>CE</given-names></name><name><surname>Warren</surname> <given-names>AL</given-names></name><name><surname>Taylor</surname> <given-names>GA</given-names></name><name><surname>Fox</surname> <given-names>BA</given-names></name><name><surname>Bzik</surname> <given-names>DJ</given-names></name><name><surname>Denkers</surname> <given-names>EY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TLR adaptor MyD88 is essential for pathogen control during oral <italic>Toxoplasma gondii</italic> infection but not adaptive immunity induced by a vaccine strain of the parasite</article-title><source>The Journal of Immunology</source><volume>181</volume><fpage>3464</fpage><lpage>3473</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.5.3464</pub-id><pub-id pub-id-type="pmid">18714019</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tashiro</surname> <given-names>H</given-names></name><name><surname>Takahashi</surname> <given-names>K</given-names></name><name><surname>Hayashi</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>G</given-names></name><name><surname>Kurata</surname> <given-names>K</given-names></name><name><surname>Kimura</surname> <given-names>S</given-names></name><name><surname>Sueoka-Aragane</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interleukin-33 from monocytes recruited to the lung contributes to house dust Mite-Induced airway inflammation in a mouse model</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0157571</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0157571</pub-id><pub-id pub-id-type="pmid">27310495</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname> <given-names>MJ</given-names></name><name><surname>Fallon</surname> <given-names>PG</given-names></name><name><surname>Matthews</surname> <given-names>DJ</given-names></name><name><surname>Jolin</surname> <given-names>HE</given-names></name><name><surname>McKenzie</surname> <given-names>ANJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>T1/St2-Deficient mice demonstrate the importance of T1/St2 in developing primary T helper cell type 2 responses</article-title><source>Journal of Experimental Medicine</source><volume>191</volume><fpage>1069</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1084/jem.191.6.1069</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripp</surname> <given-names>CS</given-names></name><name><surname>Wolf</surname> <given-names>SF</given-names></name><name><surname>Unanue</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist</article-title><source>PNAS</source><volume>90</volume><fpage>3725</fpage><lpage>3729</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.8.3725</pub-id><pub-id pub-id-type="pmid">8097322</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Grol</surname> <given-names>J</given-names></name><name><surname>Muniz-Feliciano</surname> <given-names>L</given-names></name><name><surname>Portillo</surname> <given-names>JA</given-names></name><name><surname>Bonilha</surname> <given-names>VL</given-names></name><name><surname>Subauste</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins</article-title><source>Infection and Immunity</source><volume>81</volume><fpage>2002</fpage><lpage>2011</lpage><pub-id pub-id-type="doi">10.1128/IAI.01145-12</pub-id><pub-id pub-id-type="pmid">23509150</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villeret</surname> <given-names>B</given-names></name><name><surname>Brault</surname> <given-names>L</given-names></name><name><surname>Couturier-Maillard</surname> <given-names>A</given-names></name><name><surname>Robinet</surname> <given-names>P</given-names></name><name><surname>Vasseur</surname> <given-names>V</given-names></name><name><surname>Secher</surname> <given-names>T</given-names></name><name><surname>Dimier-Poisson</surname> <given-names>I</given-names></name><name><surname>Jacobs</surname> <given-names>M</given-names></name><name><surname>Zheng</surname> <given-names>SG</given-names></name><name><surname>Quesniaux</surname> <given-names>VF</given-names></name><name><surname>Ryffel</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Blockade of IL-1R signaling diminishes paneth cell depletion and Toxoplasma gondii induced ileitis in mice</article-title><source>American Journal of Clinical and Experimental Immunology</source><volume>2</volume><fpage>107</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">23885328</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vossenkämper</surname> <given-names>A</given-names></name><name><surname>Struck</surname> <given-names>D</given-names></name><name><surname>Alvarado-Esquivel</surname> <given-names>C</given-names></name><name><surname>Went</surname> <given-names>T</given-names></name><name><surname>Takeda</surname> <given-names>K</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name><name><surname>Pfeffer</surname> <given-names>K</given-names></name><name><surname>Alber</surname> <given-names>G</given-names></name><name><surname>Lochner</surname> <given-names>M</given-names></name><name><surname>Förster</surname> <given-names>I</given-names></name><name><surname>Liesenfeld</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with <italic>Toxoplasma gondii</italic>, but IL-12 is dominant over IL-18 in parasite control</article-title><source>European Journal of Immunology</source><volume>34</volume><fpage>3197</fpage><lpage>3207</lpage><pub-id pub-id-type="doi">10.1002/eji.200424993</pub-id><pub-id pub-id-type="pmid">15368276</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>W</given-names></name><name><surname>Aste-Amezaga</surname> <given-names>M</given-names></name><name><surname>Kastelein</surname> <given-names>RA</given-names></name><name><surname>Trinchieri</surname> <given-names>G</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma</article-title><source>Journal of Immunology</source><volume>162</volume><fpage>5894</fpage><lpage>5901</lpage></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>El-Fahmawi</surname> <given-names>A</given-names></name><name><surname>Christian</surname> <given-names>DA</given-names></name><name><surname>Fang</surname> <given-names>Q</given-names></name><name><surname>Radaelli</surname> <given-names>E</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Sullivan</surname> <given-names>MC</given-names></name><name><surname>Misic</surname> <given-names>AM</given-names></name><name><surname>Ellringer</surname> <given-names>JA</given-names></name><name><surname>Zhu</surname> <given-names>XQ</given-names></name><name><surname>Winter</surname> <given-names>SE</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name><name><surname>Beiting</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Infection-Induced intestinal dysbiosis is mediated by macrophage activation and nitrate production</article-title><source>mBio</source><volume>10</volume><elocation-id>e00935-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00935-19</pub-id><pub-id pub-id-type="pmid">31138751</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>LM</given-names></name><name><surname>Dubey</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Toxoplasmosis: a history of clinical observations</article-title><source>International Journal for Parasitology</source><volume>39</volume><fpage>895</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1016/j.ijpara.2009.02.004</pub-id><pub-id pub-id-type="pmid">19217908</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weizman</surname> <given-names>OE</given-names></name><name><surname>Adams</surname> <given-names>NM</given-names></name><name><surname>Schuster</surname> <given-names>IS</given-names></name><name><surname>Krishna</surname> <given-names>C</given-names></name><name><surname>Pritykin</surname> <given-names>Y</given-names></name><name><surname>Lau</surname> <given-names>C</given-names></name><name><surname>Degli-Esposti</surname> <given-names>MA</given-names></name><name><surname>Leslie</surname> <given-names>CS</given-names></name><name><surname>Sun</surname> <given-names>JC</given-names></name><name><surname>O'Sullivan</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ILC1 confer early host protection at initial sites of viral infection</article-title><source>Cell</source><volume>171</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.052</pub-id><pub-id pub-id-type="pmid">29056343</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wherry</surname> <given-names>JC</given-names></name><name><surname>Schreiber</surname> <given-names>RD</given-names></name><name><surname>Unanue</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli</article-title><source>Infection and Immunity</source><volume>59</volume><fpage>1709</fpage><lpage>1715</lpage><pub-id pub-id-type="doi">10.1128/IAI.59.5.1709-1715.1991</pub-id><pub-id pub-id-type="pmid">1902195</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>DC</given-names></name><name><surname>Matthews</surname> <given-names>S</given-names></name><name><surname>Yap</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during <italic>Toxoplasma gondii</italic> infection</article-title><source>Journal of Immunology</source><volume>180</volume><fpage>5935</fpage><lpage>5945</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.9.5935</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>Y</given-names></name><name><surname>Lai</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Zeng</surname> <given-names>F</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Feng</surname> <given-names>H</given-names></name><name><surname>Mao</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Wu</surname> <given-names>N</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Tan</surname> <given-names>Z</given-names></name><name><surname>Gong</surname> <given-names>F</given-names></name><name><surname>Zheng</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and Glia cells</article-title><source>Molecular Immunology</source><volume>101</volume><fpage>550</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2018.08.026</pub-id><pub-id pub-id-type="pmid">30173119</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>G</given-names></name><name><surname>Pesin</surname> <given-names>M</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cutting edge: il-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii</article-title><source>The Journal of Immunology</source><volume>165</volume><fpage>628</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.165.2.628</pub-id><pub-id pub-id-type="pmid">10878333</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>GS</given-names></name><name><surname>Ortmann</surname> <given-names>R</given-names></name><name><surname>Shevach</surname> <given-names>E</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A heritable defect in IL-12 signaling in B10.Q/J mice. II. effect on acute resistance to Toxoplasma gondii and rescue by IL-18 treatment</article-title><source>Journal of Immunology</source><volume>166</volume><fpage>5720</fpage><lpage>5725</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.166.9.5720</pub-id><pub-id pub-id-type="pmid">11313414</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>GS</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999a</year><article-title>Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function</article-title><source>Immunobiology</source><volume>201</volume><fpage>240</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/S0171-2985(99)80064-3</pub-id><pub-id pub-id-type="pmid">10631573</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>GS</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999b</year><article-title>Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii</article-title><source>Journal of Experimental Medicine</source><volume>189</volume><fpage>1083</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1084/jem.189.7.1083</pub-id><pub-id pub-id-type="pmid">10190899</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarovinsky</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Andersen</surname> <given-names>JF</given-names></name><name><surname>Bannenberg</surname> <given-names>GL</given-names></name><name><surname>Serhan</surname> <given-names>CN</given-names></name><name><surname>Hayden</surname> <given-names>MS</given-names></name><name><surname>Hieny</surname> <given-names>S</given-names></name><name><surname>Sutterwala</surname> <given-names>FS</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>TLR11 activation of dendritic cells by a protozoan profilin-like protein</article-title><source>Science</source><volume>308</volume><fpage>1626</fpage><lpage>1629</lpage><pub-id pub-id-type="doi">10.1126/science.1109893</pub-id><pub-id pub-id-type="pmid">15860593</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zediak</surname> <given-names>VP</given-names></name><name><surname>Hunter</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>IL-10 fails to inhibit the production of IL-18 in response to inflammatory stimuli</article-title><source>Cytokine</source><volume>21</volume><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/S1043-4666(03)00013-9</pub-id><pub-id pub-id-type="pmid">12670447</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65614.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing Editor</role><aff><institution>The University of Queensland</institution><country>Australia</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Starkey</surname><given-names>Malcolm R</given-names></name><role>Reviewer</role><aff><institution>The University of Newcastle</institution><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/10.1101/2021.01.10.426122">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.01.10.426122v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Thank you for your comprehensive revisions. These changes greatly strengthen the work and provide insight to how IL-33 regulates ILC functions.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to <italic>Toxoplasma gondii</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Carla Rothlin as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Malcolm R Starkey (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions:</p><p>1. Delineate more clearly the roles of the different compartments and mechanistic interactions.</p><p>2. Significantly improve the technical reporting of how experiments were performed in the study. eg. not clear how infections were performed; not clear which data is referred to in the text; were controls used.</p><p>3. Clarify the models used especially the use of controls and IL-33 reporter mice.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Figure 1. Although Rag<sup>-/-</sup> mice were examined in Figure 1A, which mice the data report for the remainder of the figure has not been made clear. It is assumed that it is wild-type mice. What is the situation in the Rag<sup>-/-</sup> mice.</p><p>Figures: It would be helpful for the authors to clarify exactly how many experiments are shown in each figure. While they say &quot;Data are representative of&quot; it is often unclear whether they are actually showing pooled data, or one experiment representative of X similar independent experiments.</p><p>This work would be strengthened significantly by delineating more clearly the contributions of each compartment. This is a major confusion throughout the manuscript in trying to assess which cells are actually important in this response rather than a catalogue of cells that produce IL-33 or respond to IL-12. Thus, the causal relationships have not bee defined.</p><p>This work would benefit from a schematic to indicate how the authors believe the different cells are connected and which are the real drivers/where connections have been demonstrated in driving the immune response.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. The authors appear to &quot;force for enhance&quot; a role for IL-33 in this experimental model by injecting anti-IFN-γ antibody to the mice. Without such antibody treatment, there was undetectable level of IL-33 (Figure 1A and B) following infection of both WT and Rag deficient mice. This seriously questions the role of IL-33 in immunity. The authors should incorporate this critical concept in their discussion and emphasize that these role of ILL-33 is limited to situations where IFN-g response is suboptimal or defective.</p><p>2. It is not clear how the authors have performed infection. The only detail about the infection protocol is only explained for Figure 1A. Figure legends for other figures should include details of the infection procedure.</p><p>3. The naïve IL-33 GFP reporter mouse shows higher percentage of IL-33 compared to infected IL-33 GFP reporter mice (Figure 1C),, which is not in agreement with figures 1A and B. Given that naive mice are reporting IL-33 at about 19 times that of infected controls (albeit not coming CD5<sup>+</sup> cells), one wonders whether this reporter mice is really ideal for assessing the role of IL-33 during infection.</p><p>4. The authors should check for the role of IL-33 in neutrophil migration and expansion during early <italic>T. gondii</italic> infection.</p><p>5. Is f there any change (increase) in ILC1 and NK cells numbers in RAG<sup>-/-</sup> mice treated with rIL-33.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The manuscript by Clark et al., is well written, generally well presented and approached with scientific rigour in terms of experimental design and approach. Several comments may assist with the communication of the results to the target audience.</p><p>1. Abbreviations at first mention. Many abbreviations are used without explanation at first mention. This helps no experts follow the story. For example in introduction IL, NK, iNOS, IFN, TH2 etc. Please address all throughout where appropriate.</p><p>2. Some data panels are presented as bar graphs rather than individual points. Preference would be for all data to be presented as individual points so that the reader can get a rapid appreciation of the data, sample size etc.</p><p>3. Figure 1G. It appears in the image that the CD45+ staining has not worked optimally? Perhaps it is the image quality, but appears to be some non specific staining</p><p>4. For FACS plots, could pseudocolour plots be used? These are standard in field and easier to visualise</p><p>5. Terminology with gc<sup>-/-</sup>. In some parts is gc<sup>-/-</sup> in others IL2Rg<sup>-/-</sup>. Consistency would help here.</p><p>6. Were any studies with anti-IL-33 in infected wild-type mice performed? If not could this at least be discussed? Whilst knockout mouse models are valuable, the indirect impact of cell/factor deficiency throughout development should be considered. May disrupt immune cell development, microbiome etc.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65614.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1. Delineate more clearly the roles of the different compartments and mechanistic interactions.</p></disp-quote><p><bold>Our data support a paradigm in which in which infection with <italic>T. gondii</italic> stimulates release of IL-12 by dendritic cells but the release of IL-33 from infected stromal cells. IL-12 induces innate lymphoid cells to express the IL-33 receptor and the combination of signals from IL-12 and IL-33 stimulate ILC expansion and the production of IFN-γ. In turn, IFN-γ is responsible for the activation of monocytes that are the effector population that limits the growth of <italic>T. gondii</italic>. The text and figures have been updated to emphasize this paradigm, including new data regarding levels of IL-33R expression by CD45+ cells (Figure 1 Supplement 1E). As suggested, a model that depicts these events has been. added to the submission (Figure 6).</bold></p><disp-quote content-type="editor-comment"><p>2. Significantly improve the technical reporting of how experiments were performed in the study. eg. not clear how infections were performed; not clear which data is referred to in the text; were controls used.</p></disp-quote><p><bold>All figures have been converted to individual data points, and all figure legends have been amended to clarify that all data shown are from single experiments and representative of a specified number of replicates. The text has been updated to clarify methods and details for each experiment, including that all infections were performed i.p. (e.g., lines 136, 197, 218, 276, 295, and all figure legends). Control data in the form of knockout mice has been added to experiments as appropriate, including the addition of analysis of different tissues from IL-33<sup>-/-</sup> mice to Figure 1 Supplement 1 as validation of the reporter model.</bold></p><disp-quote content-type="editor-comment"><p>3. Clarify the models used especially the use of controls and IL-33 reporter mice.</p></disp-quote><p><bold>A discussion of the validation of the IL-33 reporter mouse has been added to the text (line 217) and knockout mouse controls for the IL-33 reporters has been adding to Figure 1 Supplement 1. In addition, details of the characterization of the Rag<sup>-/-</sup> IL-33R<sup>-/-</sup> mouse has been added to the methods section (line 125) that details the lack of overt immunological defects in the development of these mice.</bold></p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):Figure 1. Although Rag<sup>-/-</sup> mice were examined in Figure 1A, which mice the data report for the remainder of the figure has not been made clear. It is assumed that it is wild-type mice. What is the situation in the Rag<sup>-/-</sup> mice.</p></disp-quote><p><bold>In Figure 1 we use a combination of immune competent IL-33 reporter mice and ELISA to look at infection-induced changes in IL-33 levels. The reviewer is correct that the reporters were only used for WT mice as we do not have the IL-33 reporter crossed to a Rag<sup>-/-</sup> background. However, by ELISA, the levels of IL-33 in WT and Rag mice are broadly comparable (see Figure 1A) and track with levels of parasite replication.</bold></p><disp-quote content-type="editor-comment"><p>Figures: It would be helpful for the authors to clarify exactly how many experiments are shown in each figure. While they say &quot;Data are representative of&quot; it is often unclear whether they are actually showing pooled data, or one experiment representative of X similar independent experiments.</p></disp-quote><p><bold>All figures have been converted to show individual data points and figure legends amended to reflect this. All figures are data sets from individual experiments representative of multiple replicates.</bold></p><disp-quote content-type="editor-comment"><p>This work would be strengthened significantly by delineating more clearly the contributions of each compartment. This is a major confusion throughout the manuscript in trying to assess which cells are actually important in this response rather than a catalogue of cells that produce IL-33 or respond to IL-12. Thus, the causal relationships have not been defined.</p></disp-quote><p><bold>The data indicate that in vivo non-hematopoietic cells are the major source of IL-33 and that IL-12 is important for its ability to induce expression of IL-33R on ILC1 and NK cells. This point has been clarified in the Discussion section of the revised submission (line 262) and is now highlighted in the model shown in Figure 6.</bold></p><disp-quote content-type="editor-comment"><p>This work would benefit from a schematic to indicate how the authors believe the different cells are connected and which are the real drivers/where connections have been demonstrated in driving the immune response.</p></disp-quote><p><bold>A model has been included in the revised submission as Figure 6.</bold></p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. The authors appear to &quot;force for enhance&quot; a role for IL-33 in this experimental model by injecting anti-IFN-γ antibody to the mice. Without such antibody treatment, there was undetectable level of IL-33 (Figure 1A and B) following infection of both WT and Rag deficient mice. This seriously questions the role of IL-33 in immunity. The authors should incorporate this critical concept in their discussion and emphasize that these role of ILL-33 is limited to situations where IFN-g response is suboptimal or defective.</p></disp-quote><p><bold>Perhaps there has been a mis-understanding. Our data do not support the conclusion that the role of IL-33 is limited to situations where the IFN-g responses is sub-optimal or defective. It is important to note that there are elevated levels of IL-33 in Rag<sup>-/-</sup> mice, even without treatment with anti-IFN-g (Figure 1A). Additional data sets show the increased levels of IL-33<sup>+</sup> cells in WT mice without treatment with anti-IFN-g. The use of anti-IFN-g, and the use of the CPS mutants (that do not replicate) establish the link between amount of parasite replication and levels of IL-33. Moreover, the data that Rag<sup>-/-</sup> mice deficient in IL-33R show elevated parasite burdens and diminished ILC responses supports a physiological role of endogenous IL-33 in innate resistance to <italic>T. gondii</italic>. In addition, we now include data sets that (Rag sufficient) IL-33 KO have reduced levels of IFN-γ and increased weight loss at 10 dpi and elevated parasite burdens prior to entering the chronic stage of infection. These data have been added to the revised manuscript as Figure 3 Supplement 1 A and B and discussed on lines 283-284. Lastly, previous studies, that we have cited, have shown that these mice have an increased susceptibility to the chronic stage of infection.</bold></p><disp-quote content-type="editor-comment"><p>2. It is not clear how the authors have performed infection. The only detail about the infection protocol is only explained for Figure 1A. Figure legends for other figures should include details of the infection procedure.</p></disp-quote><p><bold>The revised text has been updated to indicate that all infections are intraperitoneal: line #s 136, 197, 218, 276, 295, and all figure legends.</bold></p><disp-quote content-type="editor-comment"><p>3. The naïve IL-33 GFP reporter mouse shows higher percentage of IL-33 compared to infected IL-33 GFP reporter mice (Figure 1C),, which is not in agreement with figures 1A and B. Given that naive mice are reporting IL-33 at about 19 times that of infected controls (albeit not coming CD5<sup>+</sup> cells), one wonders whether this reporter mice is really ideal for assessing the role of IL-33 during infection.</p></disp-quote><p><bold>Firstly, we do validate the use of the IL-33 reporter in Figure 1 Supplement 1 and show the fidelity between reporter and protein expression. The reviewer appears concerned about the changes in the percentage of IL-33<sup>+</sup> stromal cells. The decreased frequency of IL-33<sup>+</sup> cells observed in the omenta of infected mice is a consequence of the massive influx of CD45<sup>+</sup> cells upon infection. These data indicate that the majority of IL-33 expression is associated with CD45<sup>-</sup> cells. In addition, the overall number of IL-33<sup>+</sup> cells and the overall level of IL-33-GFP signal increases as the size of the milky spots increases, as is shown in the subsequent panels.</bold></p><disp-quote content-type="editor-comment"><p>4. The authors should check for the role of IL-33 in neutrophil migration and expansion during early T. gondii infection.</p></disp-quote><p><bold>We appreciate this suggestion. The revised manuscript includes Figure 3 Supplement 1C showing that IL-33R deficiency was associated with a 2-fold increase in the number of neutrophils in the peritoneum relative to WT mice. We now note that enhanced neutrophil responses are typically associated with increased levels of parasite replication. IL-33 treatment was not associated with any change in neutrophil numbers (data not shown). Discussion of these data is integrated into the Results section (lines 290-291, 303-304).</bold></p><disp-quote content-type="editor-comment"><p>5. Is f there any change (increase) in ILC1 and NK cells numbers in RAG<sup>-/-</sup> mice treated with rIL-33.</p></disp-quote><p><bold>Thank you for this suggestion. There was an increase in ILC1 and NK cell numbers in IL-33-treated Rag<sup>-/-</sup> mice relative to mock treated mice. These data are now included in Figure 5 of the revised manuscript and are discussed on lines 322-323.</bold></p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The manuscript by Clark et al., is well written, generally well presented and approached with scientific rigour in terms of experimental design and approach. Several comments may assist with the communication of the results to the target audience.</p><p>1. Abbreviations at first mention. Many abbreviations are used without explanation at first mention. This helps no experts follow the story. For example in introduction IL, NK, iNOS, IFN, TH2 etc. Please address all throughout where appropriate.</p></disp-quote><p>An abbreviation key has been added to the revised manuscript and key abbreviations defined on first mention.</p><disp-quote content-type="editor-comment"><p>2. Some data panels are presented as bar graphs rather than individual points. Preference would be for all data to be presented as individual points so that the reader can get a rapid appreciation of the data, sample size etc.</p></disp-quote><p><bold>Figures 1, 2, 3, 4, and 5 have been converted to individual data points.</bold></p><disp-quote content-type="editor-comment"><p>3. Figure 1G. It appears in the image that the CD45+ staining has not worked optimally? Perhaps it is the image quality, but appears to be some non specific staining</p><p>Thank you for the suggestion. CD45 display was indeed sub-optimal, it was adjusted to display dimly due to the abundance of CD45+ cells, so as to not overwhelm the merged image. The brightness of CD45 has been increased slightly in the revised Figure 1G.<italic>4. For FACS plots, could pseudocolour plots be used? These are standard in field and easier to visualise</italic></p></disp-quote><p><bold>We appreciate this suggestion and typically use a combination of plots and only use pseudocolor when there is a specific benefit, eg see Figure 1D. For the majority of our plots we prefer contour plots including outliers in part because they do not require color.</bold></p><disp-quote content-type="editor-comment"><p>5. Terminology with gc<sup>-/-</sup>. In some parts is gc<sup>-/-</sup> in others IL2Rg<sup>-/-</sup>. Consistency would help here.</p></disp-quote><p><bold>This inconsistency has been fixed.</bold></p><disp-quote content-type="editor-comment"><p>6. Were any studies with anti-IL-33 in infected wild-type mice performed? If not could this at least be discussed? Whilst knockout mouse models are valuable, the indirect impact of cell/factor deficiency throughout development should be considered. May disrupt immune cell development, microbiome etc.</p></disp-quote><p><bold>Firstly, no gross defects in Rag<sup>-/-</sup> IL33R<sup>-/-</sup> mice were observed at homeostasis. It should also be noted that (with the exception of <italic>T. gondii</italic>) IL-33 deficient mice are remarkably resistant to other infections suggesting there is no major immune deficiency in mice. The text has been revised to discuss this point (lines 125-127). We did not perform any studies inhibiting IL-33, as there is no commercially available IL-33 blocking antibody but we do now present data with Rag-sufficient IL-33 mice. In addition, the protective effects of IL-33 treatment on the ILC compartment are consistent with how the loss of IL-33 in Rag<sup>-/-</sup> mice leads to reduced ILC responses.</bold></p></body></sub-article></article>